The World Federation of Societies of Biological Psychiatry (WFSBP) 2020 guidelines for the pharmacological treatment of paraphilic disorders

References

• Abel GG, Becker JV, Cunningham-Rathner J, Mittelman M, Rouleau JL. 1988. Multiple diagnoses among sex offenders. Bull Am Acad Psychiatry Law. 16(2):153–168.
   PubMedGoogle Scholar
• Abel GG, Harlow N. 2001. The Abel and Harlow child molestation prevention study. The stop child molestation book. Philadelphia (PA): Xlibris.
   Google Scholar
• Abel GG, Huffman J, Warberg B, Holland CL. 1998. Visual reaction time and plethysmography as measures of sexual interest in child molesters. Sex Abuse. 10(2):81–95.
   Google Scholar
• Abouesh A, Clayton A. 1999. Compulsive voyeurism and exhibitionism: a clinical response to paroxetine. Arch Sex Behav. 28(1):23–30.
   PubMed Web of Science ®Google Scholar
• Adams HE, Motsinger P, McAnulty RD, Moore AL. 1992. Voluntary control of penile tumescence among homosexual and heterosexual subjects. Arch Sex Behav. 21(1):17–31.
   PubMed Web of Science ®Google Scholar
• Adi Y, Ashcroft D, Browne K, Beech A, Fry-Smith A, Hyde C. 2002. Clinical effectiveness and cost-consequences of selective serotonin reuptake inhibitors in the treatment of sexual offenders. Health Technol Assess. 6(28):1–67.
   PubMedGoogle Scholar
• Adshead G, Mezey G. 1993. Ethical issues in the psychotherapeutic treatment of paedophiles: whose side are you on? J Forensic Psychiatry. 4(2):361–368.
   Google Scholar
• Aguirre B. 1999. Fluoxetine and compulsive sexual behavior. J Am Acad Child Adolesc Psychiatry. 38(8):943.
   PubMed Web of Science ®Google Scholar
• Ahlers CJ, Schaefer GA, Mundt IA, Roll S, Englert H, Willich SN, Beier KM. 2011. How unusual are the contents of paraphilia’s? Paraphilia-associated sexual arousal patterns in a community-based sample of men. J Sex Med. 8(5):1362–1370.
   PubMed Web of Science ®Google Scholar
• Ahn J, Shim G, Lee J, Lee J, Lee T, Roh I. 2013. Preliminary study of effect of leuprolide acetate treatment on sexual fantasy of sex offenders. Korean J Leg Med. 37(3):139–144.
   Google Scholar
• Alanko K, Gunst A, Mokros A, Santtila P. 2016. Genetic variants associated with male pedophilic sexual interest. J Sex Med. 13(5):835–842.
   PubMed Web of Science ®Google Scholar
• Alanko K, Salo B, Mokros A, Santtila P. 2013. Evidence for heritability of adult men’s sexual interest in youth under age 16 from a population-based extended twin design. J Sex Med. 10(4):1090–1099.
   PubMed Web of Science ®Google Scholar
• Alanko K, Santtila P, Harlaar N, Witting K, Varjonen M, Jern P, Johansson A, von der Pahlen B, Sandnabba NK. 2010. Common genetic effects of gender atypical behavior in childhood and sexual orientation in adulthood: a study of Finnish twins. Arch Sex Behav. 39(1):81–92.
   PubMed Web of Science ®Google Scholar
• Alexander MA. 1999. Sexual offender treatment efficacy revisited. Sex Abuse. 11(2):101–116.
   PubMedGoogle Scholar
• Alexander M, Gunn J, Cook DAG, Taylor PJ, Finch J. 1993. Should a sexual offender be allowed surgical castration? Br Med Journal. 307(6907):790–793.
   PubMed Web of Science ®Google Scholar
• Allolio B, Keffel Deuss U, Winkelman W. 1985. Behandlung sexueller verhaltensstörungen mit LH-RH superagonisten. Dtsch Med Wochenscht. 110:1952.
   PubMed Web of Science ®Google Scholar
• Amelung T, Kuhle LF, Konrad A, Pauls A, Beier KM. 2012. Androgen deprivation therapy of self-identifying, help-seeking pedophiles in the Dunkelfeld. Int J Law Psychiatry. 35(3):176–184.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. 2013. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington (VA): American Psychiatric Publishing.
   Google Scholar
• Andrews DA, Bonta J. 2010. The psychology of criminal conduct. Abingdon: Routledge.
   Google Scholar
• Andrews DA, Bonta J, Wormith SJ. 2006. The recent past and near future of risk and/or need assessment. Crime Delinq. 52(1):7–27.
   Web of Science ®Google Scholar
• Assumpção AA, Garcia FD, Garcia HD, Bradford JM, Thibaut F. 2014. Pharmacologic treatment of paraphilias. Psychiatr Clin North Am. 37(2):173–181.
   PubMed Web of Science ®Google Scholar
• Babchishin KM, Hanson RK, VanZuylen H. 2015. Online child pornography offenders are different: a meta-analysis of the characteristics of online and offline sex offenders against children. Arch Sex Behav. 44(1):45–66.
   PubMed Web of Science ®Google Scholar
• Babchishin KM, Nunes KL, Hermann CA. 2013. The validity of Implicit Association Test (IAT) measures of sexual attraction to children: a meta-analysis. Arch Sex Behav. 42(3):487–499.
   PubMed Web of Science ®Google Scholar
• Bajos N, Bozon M, Beltzer N. 2008. Sexuality, prevention and gender relations during life. Med Sci. S2:5–6.
   Google Scholar
• Baker M, White T. 2002. Sex offenders in high-security care in Scotland. J Forensic Psychiatry. 13(2):285–297.
   Web of Science ®Google Scholar
• Baldwin K. 2012. Chapter 6: sex offenders risk assessment. Sex Offender Management Assessment and Planning Initiative. https://www.smart.gov/SOMAPI/sec1/ch6_risk.html
   Google Scholar
• Balon R. 1998. Pharmacological treatment of paraphilias with a focus on antidepressants. J Sex Marital Ther. 24(4):241–254.
   PubMed Web of Science ®Google Scholar
• Balon R. 2000. Lithium for paraphilias? Probably not. J Sex Marital Ther. 26(4):361–363.
   PubMed Web of Science ®Google Scholar
• Bancroft J, Tennent G, Loucas K, Cass J. 1974. The control of deviant sexual behavior by drugs. I. Behavioral changes following estrogens and antiandrogens. Br J Psychiatry. 125(586):310–315.
   PubMed Web of Science ®Google Scholar
• Banyard VL, Williams LM, Siegel JA. 2001. The long-term mental health consequences of child sexual abuse: an exploratory study of the impact of multiple traumas in a sample of women. J Traum Stress. 14(4):697–715.
   PubMed Web of Science ®Google Scholar
• Barbaree HE, Blanchard R, Langton CM. 2003. The development of sexual aggression through the life span: the effect of age on sexual arousal and recidivism among sex offenders. Ann NY Acad Sci. 989:56–71.
   Web of Science ®Google Scholar
• Barbaree HE, Marshall WL. 1989. Erectile responses amongst heterosexual child molesters, father-daughter incest offenders and matched non-offenders: five distinct age preference profils. Can J Behav Sci. 21:70–82.
   Web of Science ®Google Scholar
• Barnhill J, Cooper SA, Fletcher R. 2017. Diagnostic manual-intellectual disability 2 (DM-ID): a textbook of diagnosis of mental disorders in persons with intellectual disability. 2nd ed. Kingston (NY): NADD Press.
   Google Scholar
• Barron P, Hassiotis A, Banes J. 2004. Offenders with intellectual disability: a prospective comparative study. J Intellect Disabil Res. 48(1):69–76.
   PubMed Web of Science ®Google Scholar
• Bartholomew A. 1968. A long-acting phenothiazine as a possible agent to control deviant behaviour. Am J Psychiatry. 124(7):917–923.
   PubMed Web of Science ®Google Scholar
• Bartova D, Nahunek K, Svetka J. 1978. Pharmacological treatment of deviant sexual behavior. Act Nerv Super. 21:163–164.
   Google Scholar
• Batrinos ML. 2012. Testosterone and aggressive behavior in man. Int J Endocrinol Metab. 10(3):563–568.
   PubMedGoogle Scholar
• Baur E, Forsman M, Santtila P, Johansson A, Sandnabba K, Långström N. 2016. Paraphilic sexual interests and sexually coercive behavior: a population-based twin study. Arch Sex Behav. 45(5):1163–1172.
   PubMed Web of Science ®Google Scholar
• Beech A, Friendship C, Erikson M, Hanson RK. 2002. The relationship between static and dynamic risk factors and reconviction in a sample of UK child abusers. Sex Abuse. 14(2):155–168.
   PubMedGoogle Scholar
• Beech A, Mitchell I. 2005. A neurobiological perspective on attachment problems in sexual offenders and the role of selective serotonin reuptake inhibitors in the treatment of such problems. Clin Psychol Rev. 25(2):153–182.
   PubMed Web of Science ®Google Scholar
• Beier KM, Amelung T, Pauls A. 2010. Antiandrogen therapy as part of the prevention of child sexual abuse in the “Dunkelfeld. Forens Psychiatr Psychol Kriminol. 4(S1):49–57.
   Google Scholar
• Belchetz PE, Plant TM, Nakai Y, Keogh EJ, Knobil E. 1978. Hypophyseal responses to continuous and intermittent delivery of hypothalamic gonadotrophin-releasing hormone. Science. 202(4368):631–633.
   PubMed Web of Science ®Google Scholar
• Berlin F. 2003. Sex offender treatment and legislation. J Am Acad Psychiatry Law. 31:510–513.
   PubMed Web of Science ®Google Scholar
• Berlin F. 2009. Commentary: risk/benefit ratio of androgen deprivation treatment for sex offenders. J Am Acad Psychiatry Law. 37:59–62.
   PubMed Web of Science ®Google Scholar
• Berlin FS, Coyle GS. 1981. Psychiatric clinics at the John Hopkins Hospital. Sexual deviation syndromes. John Hopkins Med J. 149:119–125.
   PubMedGoogle Scholar
• Berlin FS, Meinecke CF. 1981. Treatment of sex offenders with antiandrogenic medication: conceptualization, review of treatment modalities, and preliminary findings. Am J Psychiatry. 138(5):601–607.
   PubMed Web of Science ®Google Scholar
• Bernat AL, Oyama K, Hamdi S, Mandonnet E, Vexiau D, Pocard M, George B, Froelich S. 2015. Growth stabilization and regression of meningiomas after discontinuation of cyproterone acetate: a case series of 12 patients. Acta Neurochir. 157(10):1741–1746.
   PubMed Web of Science ®Google Scholar
• Bhatia MS, Jhanjee A, Srivastava S, Kumar P. 2010. An uncommon case of hypersexual behaviour with frotteurism. Med Sci Law. 50(4):228–229.
   PubMed Web of Science ®Google Scholar
• Bianchi MD. 1990. Fluoxetine treatment of exhibitionism. Am J Psychiatry. 147(8):1089–1090.
   PubMed Web of Science ®Google Scholar
• Bijlsma EY, Chan JS, Olivier B, Veening JG, Millan MJ, Waldinger MD, Oosting RS. 2014. Sexual side effects of serotonergic antidepressants: mediated by inhibition of serotonin on central dopamine release? Pharmacol Biochem Behav. 121:88–101.
   PubMed Web of Science ®Google Scholar
• Björkholm C, Monteggia LM. 2016. BDNF-a key transducer of antidepressant effects. Neuropharmacology. 102:72–79.
   PubMed Web of Science ®Google Scholar
• Blanchard R. 2013. A dissenting opinion on DSM-5 pedophilic disorder. Arch Sex Behav. 42(5):675–678.
   PubMed Web of Science ®Google Scholar
• Blanchard R, Klassen P, Dickey R, Kuban ME, Blak T. 2001. Sensitivity and specificity of the phallometric test for pedophilia in nonadmitting sex offenders. Psychol Assess. 13(1):118–126.
   PubMed Web of Science ®Google Scholar
• Blanchard R, Christensen BK, Strong SM, Cantor JM, Kuban ME, Klassen P, Dickey R, Blak T. 2002. Retrospective self-reports of childhood accidents causing unconsciousness in phallometrically diagnosed pedophiles. Arch Sex Behav. 31(6):511–526.
   PubMed Web of Science ®Google Scholar
• Boer DP, Hart SD, Kropp PR, Webster CD. 1997. Manual for the sexual violence risk-20. Professional guidelines for assessing risk of sexual violence. Vancouver, Canada: Institute against Family Violence.
   Google Scholar
• Bourgeois JA, Klein M. 1996. Risperidone and fluoxetine in the treatment of pedophilia with comorbid dysthymia. J Clin Psychopharmacol. 16:257–258.
   PubMed Web of Science ®Google Scholar
• Bourget D, Bradford JM. 1987. Fire fetishism, diagnostic and clinical implications: a review of two cases. Can J Psychiatry. 32(6):459–462.
   PubMed Web of Science ®Google Scholar
• Bowden P. 1991. Treatment: use, abuse, and consent. Crim Behav Ment Health. 1(2):130–141.
   Google Scholar
• Bradford J. 1996. The role of serotonin in the future of forensic psychiatry. Bull Am Acad Psychiatry Law. 24:57–73.
   PubMedGoogle Scholar
• Bradford J. 2000. The treatment of sexual deviations using a pharmacological approach. J Sex Res. 37(3):248–257.
   Web of Science ®Google Scholar
• Bradford JM. 1983a. Research on sex offenders. Recent trends. Psychiatr Clin North Am. 6(4):715–731.
   PubMed Web of Science ®Google Scholar
• Bradford JM. 1983b. The hormonal treatment of sexual offenders. Bull Am Acad Psychiatry Law. 11(2):159–169.
   PubMedGoogle Scholar
• Bradford JM. 1999. The paraphilias, obsessive-compulsive spectrum disorder, and the treatment of sexually deviant behaviour. Psychiatr Q. 70(3):209–219.
   PubMed Web of Science ®Google Scholar
• Bradford JM. 2001. The neurobiology, neuropharmacology, and pharmacological treatment of the paraphilias and compulsive sexual behavior. Can J Psychiatry. 46 (1):26–34.
   PubMed Web of Science ®Google Scholar
• Bradford JM, Ahmed AG. 2014. The natural history of the paraphilias. Psychiatr Clin North Am. 37(2):xi–xv.
   PubMed Web of Science ®Google Scholar
• Bradford JM, Boulet J, Pawlak A. 1992. The paraphilias: a multiplicity of deviant behaviors. Can J Psychiatry. 37(2):104–108.
   PubMed Web of Science ®Google Scholar
• Bradford JM, Fedoroff P, Gulati S. 2013. Can sexual offenders be treated? Int J Law Psychiatry. 36(3-4):235–240.
   PubMed Web of Science ®Google Scholar
• Bradford JM, Gratzer TG. 1995. A treatment for impulse control disorders and paraphilia: a case report. Can J Psychiatry. 40(1):4–5.
   PubMed Web of Science ®Google Scholar
• Bradford JMW, Greenberg DM. 1996. Pharmacological treatment of deviant sexual behavior. Annu Rev Sex Behav. 7:283–306.
   Google Scholar
• Bradford J, Greenberg D, Gojer J, Martindale J, Goldberg M. 1995. Sertraline in the treatment of pedophilia: an open-label study. New research program abstracts NR 441. APA MTA, Florida. American Psychiatric Publishing.
   Google Scholar
• Bradford JM, Pawlak A. 1987. Sadistic homosexual pedophilia: treatment with cyproterone acetate: a single case study. Can J Psychiatry. 32(1):22–30.
   PubMed Web of Science ®Google Scholar
• Bradford JM, Pawlak A. 1993a. Double-blind placebo crossover study of cyproterone acetate in the treatment of the paraphilias. Arch Sex Behav. 22(5):383–402.
   PubMed Web of Science ®Google Scholar
• Bradford JM, Pawlak A. 1993b. Effects of cyproterone acetate on sexual arousal patterns of pedophiles. Arch Sex Behav. 22(6):629–641.
   PubMed Web of Science ®Google Scholar
• Bradford J, Fedoroff P. 2006. Pharmacological treatment of the juvenile sex offender. In: Barbaree H, Marshall W, editors. The juvenile sex offender. 2nd ed. Vol. 16. New York (NY): Guilford Press; p. 358–382.
   Google Scholar
• Brahams D. 1988. Voluntary chemical castration of a mental patient. Lancet. 331(8597):1291–1292.
   Google Scholar
• Bremer J. 1959. Asexualization: a follow-up study of 244 cases. New York (NY): MacMillan Co.
   Google Scholar
• Brière J, Runtz M. 1989. University males’ sexual interest in children: predicting potential indices of “pedophilia” in a nonforensic sample. Child Abuse Negl. 13(1):65–75.
   PubMed Web of Science ®Google Scholar
• Briken P. 2002. Pharmacotherapy of paraphilias with luteinizing hormone-releasing hormone agonists. Arch Gen Psychiatry. 59(5):469–470.
   PubMed Web of Science ®Google Scholar
• Briken P. 2018. Prävention sexuellen kindesmissbrauchs im dunkelfeld – das hamburger modell. Psychother Psych Med. 68(03/04):142–161.
   Google Scholar
• Briken P, Fedoroff P, Bradford J. 2014. Why can’t pedophilic disorder remit? Arch Sex Behav. 43(7):1237–1239.
   PubMed Web of Science ®Google Scholar
• Briken P, Habermann N, Berner W, Hill A. 2006. XYY chromosome abnormality in sexual homicide perpetrators. Am J Med Genet. 141B(2):198–200.
   PubMed Web of Science ®Google Scholar
• Briken P, Habermann N, Kafka MP, Berner W, Hill A. 2006. The paraphilia-related disorders: an investigation of the relevance of the concept in sexual murderers. J Forensic Sci. 51(3):683–688.
   PubMed Web of Science ®Google Scholar
• Briken P, Hill A, Berner W. 2004. A relapse in pedophilic sex offending and subsequent suicide attempt during luteinizing hormone-releasing hormone treatment. J Clin Psychiatry. 65(10):1429.
   PubMed Web of Science ®Google Scholar
• Briken P, Müller JL, Berner W, Bödeker RH, Vollmann J, Kasperk C, Koller M. 2017. Failure of a study in forensic psychiatric hospitals: clinical trial to investigate the additive effect of triptorelin on the efficacy of psychotherapy. Nervenarzt. 88(5):480–485. 2017
   PubMed Web of Science ®Google Scholar
• Briken P, Nika E, Berner W. 2001. Treatment of paraphilia with luteinizing hormone-releasing hormone agonists. J Sex Marital Ther. 27(1):45–55.
   PubMed Web of Science ®Google Scholar
• Briken P, Turner D, Thibaut F, Bradford J, Cosyns P, Tozdan S. 2018. Validation of ‘the change or stop testosterone-lowering medication (COSTLow)-scale’ using delphi method among clinical experts. J Sex Marital Ther. 24:1–25.
   Google Scholar
• Briken P, Welzel K, Habermann N, Hill A, Berner W. 2009. Antiandrogenic pharmacotherapy of sexual offenders and home leave steps in the forensic psychiatric hospital Berlin. Psychiat Prax. 36(05):232–237.
   PubMed Web of Science ®Google Scholar
• Brooks-Gordon B, Bilby C, Wells H. 2006. A systematic review of psychological interventions for sexual offenders I. Randomised control trials. J Forensic Psychiatry. 17(3):442–466.
   Google Scholar
• Burton DL, Miller DL, Shill CT. 2002. A social learning theory comparison of the sexual victimization of adolescent sexual offenders and nonsexual offending male delinquents. Child Abuse Negl. 26(9):893–907.
   PubMed Web of Science ®Google Scholar
• Bussmann H, Finger P. 2009. Anti-androgenic treatment of sex-offenders in the Forensic Psychiatric Hospital of Berlin. Forens Psychiatr Psychol Kriminol. 3(2):129–140.
   Google Scholar
• Byrne A, Brunet B, McGann P. 1992. Cyproterone acetate therapy and aggression. Br J Psychiatry. 160(2):282–283.
   PubMed Web of Science ®Google Scholar
• Cantor JM, Kabani N, Christensen BK, Zipursky RB, Barbaree HE, Dickey R, Klassen PE, Mikulis DJ, Kuban ME, Blak T, et al. 2008. Cerebral white matter deficiencies in pedophilic men. J Psychiatr Res. 42(3):163–183.
   PubMed Web of Science ®Google Scholar
• Carani C, Bancroft J, Granata A, Del Rio G, Marrama P. 1992. Testosterone and erectile function, nocturnal penile tumescence and rigidity, and erectile response to visual erotic stimuli in hypogonadal and eugonadal men. Psychoneuroendocrinology. 17(6):647–654.
   PubMed Web of Science ®Google Scholar
• Castellini G, Rellini AH, Appignanesi C, Pinucci I, Fattorini M, Grano E, Fisher AD, Cassioli E, Lelli L, Maggi M, et al. 2018. Deviance or normalcy? The relationship among paraphilic thoughts and behaviors, hypersexuality, and psychopathology in a sample of university students. J Sex Med. 15(9):1322–1335.
   PubMed Web of Science ®Google Scholar
• Cea-Soriano L, Blenk T, Wallander MA, Rodríguez LA. 2012. Hormonal therapies and meningioma: is there a link? Cancer Epidemiol. 36(2):198–205.
   PubMed Web of Science ®Google Scholar
• Cesnik JA, Coleman E. 1989. Use of lithium carbonate in the treatment of autoerotic asphyxia. Am J Psychother. 43(2):277–286.
   PubMed Web of Science ®Google Scholar
• Chagraoui A, Thibaut F. 2016. Should sexual offending be considered an addiction? Implications for prevention and treatment approaches. Curr Addict Rep. 3(4):414–135.
   Google Scholar
• Chanson P, Schaison G. 1995. Pituitary apoplexy caused by GnRH-agonist treatment revealing gonadotroph adenoma. J Clin Endocrinol Metab. 80(7):2267–2268.
   PubMed Web of Science ®Google Scholar
• Choi JH, Lee JW, Lee JK, Jang S, Yoo M, Lee D, Hong JW, I Noh IS, Lim MH. 2018. Therapeutic effects of leuprorelin (Leuprolide acetate) in sexual offenders with paraphilia. J Korean Med Sci. 33(37):e231.
   PubMed Web of Science ®Google Scholar
• Chow EW, Choy A. 2002. Clinical characteristics and treatment response to SSRI in a female pedophile. Arch Sex Behav. 31(2):211–215.
   PubMed Web of Science ®Google Scholar
• Clayton A, Keller A, McGarvey EL. 2006. Burden of phase-specific sexual dysfunction with SSRIs. J Affect Disord. 91(1):27–32.
   PubMed Web of Science ®Google Scholar
• Cohen LJ, Frenda S, Mojtabai R, Katsavdakis K, Galynker I. 2007. Comparison of sexual offenders against children with sex offender registry. J Psychiatr Pract. 13(6):373–384.
   PubMedGoogle Scholar
• Cohen LJ, Galynker II. 2002. Clinical features of pedophilia and implications for treatment. J Psychiatr Pract. 8:276–289.
   PubMedGoogle Scholar
• Cohen L, Ndukwe N, Yaseen Z, Galynker I. 2018. Comparison of self-identified minor-attracted persons who have and have not successfully refrained from sexual activity with children. J Sex Marital Ther. 44(3):217–230.
   PubMed Web of Science ®Google Scholar
• Cohen LJ, Nikiforov K, Gans S, Poznansky O, McGeoch P, Weaver C, King EG, Cullen K, Galynker I. 2002. Heterosexual male perpetrators of childhood sexual abuse: a preliminary neuropsychiatric model. Psychiatr Q. 73(4):313–336.
   PubMed Web of Science ®Google Scholar
• Coleman E, Cesnik J, Moore AM, Dwyer SM. 1992. An exploratory study of the role of psychotropic medications in treatment of sexual offenders. J Rehab. 18(3–4):75–88.
   Google Scholar
• Cooper AJ. 1981. A placebo-controlled trial of the antiandrogen cyproterone acetate in deviant hypersexuality. Compr Psychiatry. 22(5):458–465.
   PubMed Web of Science ®Google Scholar
• Cooper AJ. 1986. Progestagens in the treatment of male sexual offenders: a review. Can J Psychiatry. 31(1):73–79.
   PubMed Web of Science ®Google Scholar
• Cooper AJ. 1987. Medroxyprogesterone acetate (MPA) treatment of sexual acting out in men suffering from dementia. J Clin Psychiatry. 48(9):368–370.
   PubMed Web of Science ®Google Scholar
• Cooper AJ. 1988. Medroxyprogesterone acetate as a treatment for sexual acting out in organic brain syndrome. Am J Psychiatry. 145(9):1179–1180.
   PubMed Web of Science ®Google Scholar
• Cooper AJ. 1995. Review of the role of two anti-libidinal drugs in the treatment of sex offenders with mental retardation. Ment Retard. 33(1):42–48.
   PubMedGoogle Scholar
• Cooper AJ, Cernovsky Z, Magnus RV. 1992. The long-term use of cyproterone acetate in pedophilia: a case study. J Sex Marital Ther. 18(4):292–302.
   PubMed Web of Science ®Google Scholar
• Cooper AJ, Ismail AA, Phanjoo AL, Love DL. 1972. Antiandrogen (Cyproterone acetate) therapy in deviant hypersexuality. Br J Psychiatry. 120(554):59–63.
   PubMed Web of Science ®Google Scholar
• Cooper AJ, Losztyn S, Russell NC, Cernovsky Z. 1990. Medroxyprogesterone acetate, nocturnal penile tumescence, laboratory arousal, and sexual acting out in a male with schizophrenia. Arch Sex Behav. 19(4):361–372.
   PubMed Web of Science ®Google Scholar
• Cooper AJ, Sandhu S, Losztyn S, Cernovsky Z. 1992. A double-blind placebo-controlled trial of medroxyprogesterone acetate and cyproterone acetate with seven pedophiles. Can J Psychiatry. 37(10):687–693.
   PubMed Web of Science ®Google Scholar
• Cooper AJ, Cernovsky Z. 1992. The effects of cyproterone acetate on sleeping and waking penile erections in pedophiles: possible implications for treatment. Can J Psychiatry. 37(1):33–39.
   PubMed Web of Science ®Google Scholar
• Cooper AJ, Cernovsky ZZ. 1994. Comparison of cyproterone acetate and leuprolide acetate (LHRH agonist) in a chronic pedophile: a clinical case study. Biol Psychiatry. 36(4):269–271.
   PubMed Web of Science ®Google Scholar
• Cordoba OA, Chapel JL. 1983. Medroxyprogesterone acetate antiandrogen treatment of hypersexuality in a pedophiliac sex offender. Am J Psychiatry. 140(8):1036–1039.
   PubMed Web of Science ®Google Scholar
• Cornu F. 1973. Case histories of castrated sex offenders from a forensic psychiatric viewpoint. Bibl Psychiatr. 149:1–132.
   PubMedGoogle Scholar
• Coskun M, Karakoc S, Kircelli F, Mukaddes NM. 2009. Effectiveness of mirtazapine in the treatment of inappropriate sexual behaviours in individuals with autistic disorder. J Child Adolesc Psychopharmacol. 19(2):203–206.
   PubMed Web of Science ®Google Scholar
• Coskun M, Mukaddes NM. 2008. Mirtazapine treatment in a subject with autistic disorder and fetishism. J Child Adolesc Psychopharmacol. 18(2):206–209.
   PubMed Web of Science ®Google Scholar
• Cosyns P, Thibaut F. 2017. La psychopharmacologie. In: Cortoni F, Pham T, editors. Traité de l’agression sexuelle. Théories explicatives, évaluation et traitement des agresseurs sexuels. Vol. 9. Canada: Mardaga; p. 179–197.
   Google Scholar
• Craig LA, Browne KD, Stringer I, Hogue TE. 2008. Sexual reconviction rates in the United Kingdom and actual risk estimates. Child Abuse Negl. 32(1):121–138.
   PubMed Web of Science ®Google Scholar
• Creighton S. 2002. Recognising changes in incidence and prevalence. In: Browne K, Hanks H, Stratton P, Hamilton C, editors. Early prediction and prevention of child abuse: a handbook. Chichester, England: J Wiley and Sons; p. 5–22.
   Google Scholar
• Czerny JP, Briken BW. 2002. Antihormonal treatment of paraphilic patients in German forensic psychiatric clinics. Eur Psychiatry. 17(2):104–106.
   PubMed Web of Science ®Google Scholar
• Davies TS. 1974. Cyproterone acetate for male hypersexuality. J Int Med Res. 2(2):159–163.
   PubMed Web of Science ®Google Scholar
• Dawson SJ, Bannerman BA, Lalumière ML. 2016. Paraphilic interests: an examination of sex differences in a nonclinical sample. Sex Abuse. 28(1):20–45.
   PubMed Web of Science ®Google Scholar
• Dawson N, Ferrington L, Olverman HJ, Harmar AJ, Kelly PAT. 2009. Sex influences the effect of a lifelong increase in serotonin transporter function on cerebral metabolism. J Neurosci Res. 87(10):2375–2385.
   PubMed Web of Science ®Google Scholar
• Dellis A, Papatsoris A. 2017. Therapeutic outcomes of the LHRH antagonists. Expert Rev Pharm Outcomes Res. 17(5):481–488.
   Google Scholar
• Dennis J, Huband N, Khan O, Ferriter M, Jones H, Powney M. 2012. Psychological interventions for adults who have sexually offended or are at risk of offending. Cochrane Database Syst Rev. 12:CD007507.
   PubMed Web of Science ®Google Scholar
• Dickey R. 1992. The management of a case of treatment-resistant paraphilia with a long-acting LHRH agonist. Can J Psychiatry. 37(8):567–569.
   PubMed Web of Science ®Google Scholar
• Dickey R. 2002. Case report: the management of bone demineralization associated with long term treatment of multiple paraphilia with long-acting LHRH agonists. J Sex Marital Ther. 28(3):207–210.
   PubMed Web of Science ®Google Scholar
• Dickey R, Nussbaum D, Chevolleau K, Davidson H. 2002. Age as a differential characteristic of rapists, pedophiles, and sexual sadists. J Sex Marital Ther. 28(3):211–218.
   PubMed Web of Science ®Google Scholar
• Dodson WE, Al-Aish MS, Alexander DF. 1972. Cytogenetic survey of XYY males in two juvenile court populations, with a case report. J Med Genet. 9(3):287–288.
   PubMed Web of Science ®Google Scholar
• Dombert B, Schmidt AF, Banse R, Briken P, Hoyer J, Neutze J, Osterheider M. 2016. How common is men’s self-reported sexual interest in prepubescent children? J Sex Res. 53(2):214–223.
   PubMed Web of Science ®Google Scholar
• Dunsieth NW, Nelson EB, Brusman-Lovins LA, Holcomb JL, Beckman D, Welge JA, Roby D, Taylor P, Soutullo CA, McElroy SL. 2004. Psychiatric and legal features of 113 men convicted of sexual offenses. J Clin Psychiatry. 65(3):293–300.
   PubMed Web of Science ®Google Scholar
• Eibl E. 1978. Treatment and after-care of 300 sex offenders, especially with regard to penile plethysmography. Justizministerium. Baden-Württemberg. Proceedings of the German Conference on Treatment Possibilities for Sex Offenders in Eppingen. Stuttgart, Germany.
   Google Scholar
• Elger BS. 2008. Research involving prisoners: consensus and controversies in international and European regulations. Bioethics. 22(4):224–238.
   PubMed Web of Science ®Google Scholar
• Elliott M, Browne K, Kilcoyne J. 1995. Child sexual abuse prevention: what offenders tell us. Child Abuse Neglect. 19(5):579–594.
   PubMed Web of Science ®Google Scholar
• Elliott E, Vollm B. 2016. The utility of post-conviction polygraph testing among sexual offenders. Sex Abuse. 30(4):367–392.
   PubMed Web of Science ®Google Scholar
• Ellis H. 1933. Psychology of sex. London: William Heinemann.
   Google Scholar
• Emmanuel MP, Lydiard RB, Ballenger JC. 1991. Fluoxetine treatment of voyeurism. Am J Psychiatry. 148:950.
   PubMed Web of Science ®Google Scholar
• Engel J, Veit M, Sinke C, Heitland I, Kneer J, Hillemacher T, Hartmann U, Kruger T. 2019. Same same but different: a clinical chararcterization of men with hypersexual disorder in the sex@brain study. J Clin Med. 8(2):pil:E157.
   Web of Science ®Google Scholar
• Eriksson T, Eriksson M. 1998. Irradiation therapy prevents gynecomastia in sex offenders treated with antiandrogens. J Clin Psychiatry. 59(8):432–433.
   PubMed Web of Science ®Google Scholar
• Fedoroff J. 1995. Antiandrogens versus serotoninergic medications in the treatment of sex offenders: a preliminary compliance study. Can J Hum Sex. 4:111–123.
   Google Scholar
• Fedoroff JP. 1991. Interview techniques to assess sexual disorders. Fam Soc. 72(3):140–146.
   Web of Science ®Google Scholar
• Fedoroff JP. 1992. Buspirone hydrochloride in the treatment of an atypical paraphilia. Arch Sex Behav. 21(4):401–406.
   PubMed Web of Science ®Google Scholar
• Fedoroff JP. 2008. Sadism, sadomasochism, sex, and violence. Can J Psychiatry. 53(10):637–646.
   PubMed Web of Science ®Google Scholar
• Fedoroff JP. 2009. The paraphilias. In: Gelder MG, Andereasen NC, Lopez-Iber JJ. Jr., Beddes JR, editors. The new Oxford textbook of psychiatry. 2nd ed. Oxford: Oxford University Press; p. 832–842.
   Google Scholar
• Fedoroff JP. 2010. Paraphilic worlds. In: Levine SB, editor. Handbook of clinical sexuality for mental health professionals. New York (NY): Routledge; p. 401–424.
   Google Scholar
• Fedoroff JP. 2016. Managing versus successfully treating paraphilic disorders: the paradigm is changing. In: Levine SB, Risen CB, Althof SE, editors. Handbook of clinical sexuality for mental health professionals. New York (NY): Taylor and Francis; p. 345–361.
   Google Scholar
• Fedoroff JP. 2018. More puzzles: a response to seto’s (2017) “the puzzle of male chronophilias. Arch Sex Behav. 47(8):2171–2173.
   PubMed Web of Science ®Google Scholar
• Fedoroff JP, Marshall WL. 2010. Paraphilias. In: McKay D, Abramowitz JS, Taylor S. editors. Cognitive behavioral therapy for refractory cases. Washington (DC): American Psychological Association; p. 369–384.
   Google Scholar
• Fedoroff JP, Peyser C, Franz ML, Folstein S. 1994. Sexual disorders in Huntington’s disease. J Neuropsychiatr Clin Neurosci. 6:147–153.
   PubMed Web of Science ®Google Scholar
• Fedoroff JP, Pinkus S. 1996. The genesis of pedophilia: testing the abuse to abuser hypothesis. J off Rehab. 23(3–4):85–101.
   Google Scholar
• Fenichel O. 1954. The Psychology of transvestism “collected papers.London: Routledge and Kegan.
   Google Scholar
• Fernandez HH, Durso R. 1998. Clozapine for dopaminergic-induced paraphilias in Parkinson’s disease. Mov Disord. 13(3):597–598.
   PubMed Web of Science ®Google Scholar
• Field LH. 1973. The treatment of sexual offenders. Med Sci Law. 13(3):195–196.
   PubMed Web of Science ®Google Scholar
• Firestone P, Bradford JM, Greenberg DM, Larose MR. 1998. Homicidal sex offenders: psychological, phallometric, and diagnostic features. J Am Acad Psychiatry Law. 26(4):537–552.
   PubMed Web of Science ®Google Scholar
• Firoz K, Nidheesh Sankar V, Rajmohan V, Manoj Kumar G, Raghuram TM. 2014. Treatment of fetishism with naltrexone: a case report. Asian J Psychiatr. 8:67–68.
   PubMedGoogle Scholar
• Fong TW, De la Garza RH, Newton TF. 2005. A case report of topiramate in the treatment of nonparaphilic sexual addiction. J Clin Psychopharmacol. 25:512–514.
   PubMed Web of Science ®Google Scholar
• Foote R. 1944. Hormone treatment of sex offenders. J Nerv Ment Dis. 99(6):928–929.
   Google Scholar
• Fosdick C, Mohiuddin S. 2016. Case report: resolution of severe sexual aggression in a developmentally disabled adolescent during leuprolide acetate use. J Autism Dev Disord. 46(6):2267–2269.
   PubMed Web of Science ®Google Scholar
• Freud S. 1905/1953. Three essays on the theory of sexuality. Complete psychological works of Sigmund Freud. Standard edition. Vol. 7. London: Hogarth Press.
   Google Scholar
• Friedman G, Lamoureux E, Sherker AH. 1999. Fatal fulminant hepatic failure due to cyproterone acetate. Dig Dis Sci. 44(7):1362–1363.
   PubMed Web of Science ®Google Scholar
• Frokjaer VG, Pinborg A, Holst KK, Overgaard A, Henningsson S, Heede M, Larsen EC, Jensen PS, Agn M, Nielsen AP, et al. 2015. Role of serotonin transporter changes in depressive responses to sex-steroid hormone manipulation: a positron emission tomography study. Biol Psychiatry. 78(8):534–543.
   PubMed Web of Science ®Google Scholar
• Fromberger P, Jordan K, Müller JL. 2018. Virtual reality applications for diagnosis, risk assessment and therapy of child abusers. Behav Sci Law. 36(2):235–244.
   PubMed Web of Science ®Google Scholar
• Fromberger P, Jordan K, Steinkrauss H, von Herder J, Witzel J, Stolpmann G, Kröner Herwig B, Müller JL. 2012. Diagnostic accuracy of eye movements in assessing Pedophilia. J Sex Med. 9(7):1868–1882.
   PubMed Web of Science ®Google Scholar
• Füllhase C, Soler R, Gratzke C. 2014. New strategies in treating male lower urinary tract symptoms. Curr Opin Urol. 24(1):29–35.
   PubMed Web of Science ®Google Scholar
• Gaffney GR, Berlin FS. 1984. Is there hypothalamic-pituitary-gonadal dysfunction in paedophilia? Br J Psychiatry. 145(6):657–660.
   PubMed Web of Science ®Google Scholar
• Gaffney GR, Lurie SF, Berlin FS. 1984. Is there familial transmission of pedophilia? J Nerv Ment Dis. 172(9):546–548.
   PubMed Web of Science ®Google Scholar
• Gagné P. 1981. Treatment of sex offenders with medroxyprogesterone acetate. Am J Psychiatry. 138(5):644–646.
   PubMed Web of Science ®Google Scholar
• Gallagher CA, Wilson DB, Hirschfield P, Coggeshall MB, MacKenzie DL. 1999. A quantitative review of the effects of sex offender treatment on sexual reoffending. Correct Manag Quart. 3:19–29.
   Google Scholar
• Gallo A, Abracen J, Looman J, Jeglic E, Dickey R. 2019. The use of leuprolide acetate in the management of high-risk sex offenders. Sex Abuse. 31(8):930–951.
   PubMed Web of Science ®Google Scholar
• Gannon TA, Olver ME, Mallion JS, James M. 2019. Does specialized psychological treatment for offending reduce recidivism? A meta-analysis examining staff and program variables as predictors of treatment effectiveness. Clin Psychol Rev. 73:101752.
   PubMed Web of Science ®Google Scholar
• Garcia FD, Thibaut F. 2010. Sexual addictions. Am J Drug Alcohol Abuse. 36(5):254–260.
   PubMed Web of Science ®Google Scholar
• Garcia FD, Thibaut F. 2011. Current concepts in the pharmacotherapy of paraphilias. Drugs. 71(6):771–790.
   PubMed Web of Science ®Google Scholar
• García-Malpartida K, Martín-Gorgojo A, Rocha M, Gómez-Balaguer M, Hernández-Mijares A. 2010. Prolactinoma induced by estrogen and cyproterone acetate in a male-to-female transsexual. Fertil Steril. 94(3):1097.e13–5.
   Web of Science ®Google Scholar
• Gerardin P, Thibaut F. 2004. Epidemiology and treatment of juvenile sexual offending. Paediatr Drugs. 6(2):79–91.
   PubMedGoogle Scholar
• Gerwinn H, Pohl A, Granert O, van Eimeren T, Wolff S, Jansen O, Deuschl G, Huchzermeier C, Stirn A, Siebner HR, et al. 2015. The (in)consistency of changes in brain macrostructure in male paedophiles: a combined T1-weighted and diffusion tensor imaging study. J Psychiatr Res. 68:246–253.
   PubMed Web of Science ®Google Scholar
• Gijs L, Gooren L. 1996. Hormonal and psychopharmacological interventions in the treatment of paraphilias: an update. J Sex Res. 33(4):273–290.
   Web of Science ®Google Scholar
• Gil M, Oliva B, Timoner J, Maciá MA, Bryant V, de Abajo FJ. 2011. Risk of meningioma among users of high doses of cyproterone acetate as compared with the general population: evidence from a population-based cohort study. Br J Clin Pharmacol. 72(6):965–968.
   PubMed Web of Science ®Google Scholar
• Gillessen S, Templeton A, Marra G, Kuo YF, Valtorta E, Shahinian VB. 2010. Risk of colorectal cancer in men on long-term androgen deprivation therapy for prostate cancer. J Natl Cancer Inst. 102(23):1760–1770.
   PubMedGoogle Scholar
• Giltay EJ, Gooren L. 2009. Potential side effects of androgen deprivation treatment in sex offenders. J Am Acad Psychiatry Law. 37:53–58.
   PubMed Web of Science ®Google Scholar
• Goldman Juliette DG, Padayachi UK. 2000. Some methodological problems in estimating incidence and prevalence in child sexual abuse research. J Sex Res. 37(4):305–314.
   Web of Science ®Google Scholar
• Golla FL, Hodge SR. 1949. Hormone treatment of sexual offenders. Lancet. 253(6563):1006–1007.
   Google Scholar
• Gołyszny M, Obuchowicz E. 2019. Are neuropeptides relevant for the mechanism of action of SSRIs? Neuropeptides. 75:1–17.
   PubMed Web of Science ®Google Scholar
• Gooren LJ, Lips P, Gijs L. 2001. Osteoporosis and androgen-depleting drugs in sex offenders. Lancet. 357(9263):1208–1209.
   PubMed Web of Science ®Google Scholar
• Gordon H. 2008. The treatment of paraphilias. An historical perspective. Crim Behav Ment Health. 18(2):79–87.
   PubMedGoogle Scholar
• Gordon H, Grubin D. 2004. Psychiatric aspects of the assessment and treatment of sex offenders. Adv Psychiatr Treat. 10(1):73–80.
   Google Scholar
• Gottesman HG, Schubert DS. 1993. Low-dose oral medroxyprogesterone acetate in the management of the paraphilias. J Clin Psychiatry. 54(5):182–188.
   PubMed Web of Science ®Google Scholar
• Grasswick LJ, Bradford JM. 2003. Osteoporosis associated with the treatment of paraphilias: a clinical review of seven case reports. J Forensic Sci. 48:849–855.
   PubMed Web of Science ®Google Scholar
• Gratzer T, Bradford JM. 1995. Offender and offense characteristics of sexual sadists: a comparative study. J Forensic Sci. 40(3):450–455.
   PubMed Web of Science ®Google Scholar
• Gray SR, Abel GG, Jordan A, Garby T, Wiegel M, Harlow N. 2015. Visual reaction time™ as a predictor of sexual offense recidivism. Sex Abuse. 27(2):173–188.
   PubMed Web of Science ®Google Scholar
• Green AH. 1999. Female sex offenders. In: Shaw JA, editor. Sexual aggression. Washington (DC): American Psychiatric Press; p. 195–210.
   Google Scholar
• Greenberg DM. 1998. Sexual recidivism in sex offenders. Can J Psychiatry. 43(5):459–465.
   PubMed Web of Science ®Google Scholar
• Greenberg DM, Bradford J. 1997. Treatment of the paraphilic disorders: a review of the role of the selective serotonin reuptake inhibitors. Sex Abuse. 9(4):349–360.
   Google Scholar
• Greenberg DM, Bradford JMW, Curry S, O’Rourke A. 1996. A comparison of treatment of paraphilias with three serotonin reuptake inhibitors: a retrospective study. Bull Am Acad Psychiatry Law. 24(4):525–532.
   PubMedGoogle Scholar
• Greenwald AG, Banaji MR. 2017. The implicit revolution: reconceiving the relation between conscious and unconscious. Am Psychol. 72(9):861–871.
   PubMed Web of Science ®Google Scholar
• Griffiths DM, Fedoroff JP. 2014. Persons with intellectual disabilities and problematic sexual behaviors. Psychiatr Clin North Am. 37(2):195–206.
   PubMed Web of Science ®Google Scholar
• Griffiths D, Hingsburger D, Hoath J, Ioannou S. 2013. Counterfeit deviance’ revisited. J Appl Res Intellect Dis. 26:471–480.
   Web of Science ®Google Scholar
• Grinshpoon A, Levy A, Rapoport A, Rabinowitz S. 1991. Cyproterone acetate treatment and sexual disinhibition. Med Law. 10(6):609–613.
   PubMedGoogle Scholar
• Grønnerød C, Grønnerød JS, Grøndahl P. 2015. Psychological treatment of sexual offenders against children: a meta-analytic review of treatment outcome studies. Trauma Viol Abuse. 16(3):280–290.
   PubMed Web of Science ®Google Scholar
• Grossman LS, Martis B, Fichtner CG. 1999. Are sex offenders treatable? A research overview. PS. 50(3):349–391.
   Google Scholar
• Group for the Advancement of Psychiatry. 2000. Homosexuality and the mental health professions: the impact of bias. London: Analytic Press.
   Google Scholar
• Guay D. 2008. Inappropriate sexual behaviors in cognitively impaired older individuals. Am J Ger Pharmacother. 6(5):269–288.
   PubMedGoogle Scholar
• Guay D. 2009. Drug treatment of paraphilic and nonparaphilic sexual disorders. Clin Ther. 31(1):1–31.
   PubMed Web of Science ®Google Scholar
• Habermeyer B, Esposito F, Händel N, Lemoine P, Klarhöfer M, Mager R, Dittmann V, Seifritz E, Graf M. 2013. Immediate processing of erotic stimuli in paedophilia and controls: a case-control study. BMC Psychiatry. 13(1):88.
   PubMed Web of Science ®Google Scholar
• Habermeyer B, Esposito F, Händel N, Lemoine P, Kuhl HC, Klarhöfer M, Mager R, Mokros A, Dittmann V, Seifritz E, et al. 2013. Response inhibition in pedophilia: an fMRI pilot study. Neuropsychobiology. 68(4):228–237.
   PubMed Web of Science ®Google Scholar
• Habermeyer B, Händel N, Lemoine P, Klarhöfer M, Seifritz E, Dittmann V, Graf M. 2012. LH-RH agonists modulate amygdala response to visual sexual stimulation: a single case fMRI study in pedophilia. Neurocase. 18(6):489–495.
   PubMed Web of Science ®Google Scholar
• Hall GC. 1995. Sexual offender recidivism revisited: a meta-analysis of recent treatment studies. J Consult Clin Psychol. 63(5):802–809.
   PubMed Web of Science ®Google Scholar
• Hall RC, Hall R. 2007. A profile of pedophilia: definition, characteristics of offenders, recidivism, treatment outcomes, and forensic issues. Mayo Clin Proc. 82(4):457–471.
   PubMed Web of Science ®Google Scholar
• Hansen H, Lykke-Olesen L. 1997. Treatment of dangerous sexual offenders in Denmark. J Forensic Psychiatry. 8(1):195–199.
   Web of Science ®Google Scholar
• Hanson RK, Bussiere MT. 1998. Predicting relapse: a meta-analysis of sexual offender recidivism studies. J Consult Clin Psychol. 66(2):348–362.
   PubMed Web of Science ®Google Scholar
• Hanson RK, Gordon A, Harris AJ, Marques JK, Murphy W, Quinsey VL, Seto MC. 2002. First report of the collaborative outcome data project on the effectiveness of psychological treatment for sex offenders. Sex Abuse. 14(2):169–194. discussion 195-197.
   PubMedGoogle Scholar
• Hanson RK, Morton KE, Harris AJ. 2006. Sexual offender recidivism risk: what we know and what we need to know. Ann NY Acad Sci. 989(1):154–166. discussion 236-246.
   Google Scholar
• Hanson RK, Morton-Bourgon KE. 2005. The characteristics of persistent sexual offenders: a meta-analysis of recidivism studies. J Consult Clin Psychol. 73(6):1154–1163.
   PubMed Web of Science ®Google Scholar
• Hanson RK, Harris AJR, Scott TL, Helmus L. 2007. Assessing the risk of sexual offenders on community supervision: the Dynamic Supervision Project. Public Safety Canada; p. 1–53. https://www.publicsafety.gc.ca/cnt/rsrcs/pblctns/ssssng-rsk-sxl-ffndrs/index-en.aspx
   Google Scholar
• Hanson RK, Morton-Bourgon KE. 2009. The accuracy of recidivism risk assessments for sexual offenders: a meta-analysis of 118 prediction studies. Psychol Assess. 21(1):1–21.
   PubMed Web of Science ®Google Scholar
• Hanson RK, Thornton D. 2000. Improving risk assessments for sex offenders: a comparison of three actuarial scales. Law Hum Behav. 24(1):119–136.
   PubMed Web of Science ®Google Scholar
• Hare RD. 2003. The psychopathy checklist-revised. 2nd ed. Toronto, Canada: Multi-Health Systems.
   Google Scholar
• Harris J, Grace SA. 1999. A question of evidence? Investigating and prosecuting rape in the 1990s. London: The Stationery Office Limited
   Google Scholar
• Harris AJR, Hanson RK. 2004. La récidive sexuelle: d’une simplicité trompeuse. Ottawa, Canada: Sécurité publique et Protection civile Canada.
   Google Scholar
• Harris A, Phenix A, Harrison RK, Thornton D. 2003. Static 99. Coding rules. Ottawa, Canada: Department of Solicitor General of Canada.
   Google Scholar
• Heim N. 1981. Sexual behaviour of castrated sex offenders. Arch Sex Behav. 10(1):11–19.
   PubMed Web of Science ®Google Scholar
• Heim N, Hursch CJ. 1979. Castration for sex offenders: treatment or punishment? A review and critique of recent European literature. Arch Sex Behav. 8(3):281–304.
   PubMed Web of Science ®Google Scholar
• Heinemann LAJ, Will-Shahab L, VAN Kesteren P, Gooren LJG.; THE COLLABORATING CENTRES. 1997. Safety of cyproterone acetate: report of active surveillance. Pharm Drug Safe. 6(3):169–178.
   PubMed Web of Science ®Google Scholar
• Heller CG, Laidlaw WM, Harvey HT, Nelson WO. 1958. Effects of progestational compounds on the reproductive process of the human male. Ann NY Acad Sci. 71(5):649–655.
   PubMed Web of Science ®Google Scholar
• Hensley C, Tewksbury R. 2003. In: Hensley C, Tewksbury R, editors. A reader: sexual deviance London. Boulder (CO): Lynne Rienner.
   Google Scholar
• Heyns CF, Simonin MP, Grosgurin P, Schall R, Porchet HC.; for the South African Triptorelin Study Group. 2003. Comparative efficacy of triptorelin pamoate and leuprolide acetate in men with advanced prostate cancer. BJU Int. 92(3):226–231.
   PubMed Web of Science ®Google Scholar
• Higley JD, Mehlman PT, Poland RE, Taub DM, Vickers J, Suomi SJ, Linnoila M. 1996. Testosterone and 5-HIAA correlate with different types of aggressive behaviors. Biol Psychiatry. 40(11):1067–1082.
   PubMed Web of Science ®Google Scholar
• Hill A, Briken P, Kraus C, Strohm K, Berner W. 2003. Differential pharmacological treatment of paraphilias and sex offenders. Int J Offender Ther Comp Criminol. 47(4):407–421.
   PubMed Web of Science ®Google Scholar
• Hill D, Pond DA, Mitchell W, Falconer MA. 1957. Personality changes following temporal lobectomy for epilepsy. J Ment Sci. 103(430):18–27.
   PubMed Web of Science ®Google Scholar
• Hirschfield M. 1948. Sexual anomalies and perversions. London: Francis Alder.
   Google Scholar
• Ho DK, Kottalgi G, Ross CC, Romero-Ulceray J, Das M. 2012. Treatment with triptorelin in mentally disordered sex offenders. Experience from a maximum-security hospital. J Clin Psychopharmacol. 32(5):739–740.
   PubMed Web of Science ®Google Scholar
• Holoyda BJ, Kellaher DC. 2016. The biological treatment of paraphilic disorders: an updated review. Curr Psychiatry Rep. 18(2):19.
   PubMed Web of Science ®Google Scholar
• Hoogeveen GH, Van Der Veer E. 2008. Side effects of pharmacotherapy on bone with long-acting gonadorelin agonist triptorelin for paraphilia. J Sex Med. 5(3):626–630.
   PubMed Web of Science ®Google Scholar
• Hucker S, Langevin R, Bain J. 1988. A double-blind trial of sex drive reducing medication in pedophiles. Ann Sex Res. 1:27–247.
   Google Scholar
• Hucker S, Langevin R, Wortzman G, Bain J, Handy L, Chambers J, Wright S. 1986. Neuropsychological impairment in pedophiles. Sex Abuse. 18(4):440–448.
   Google Scholar
• Huygh J, Verhaegen A, Goethals K, Cosyns P, De Block C, Van Gaal L. 2015. Prolonged flare-up of testosterone after administration of a gonadotrophin agonist to a sex offender: an under-recognized risk? Crim Behav Ment Health. 25(3):226–230.
   PubMed Web of Science ®Google Scholar
• Imhoff R, Schmidt AF, Weiß S, Young AW, Banse R. 2012. Vicarious viewing time: prolonged response latencies for sexually attractive targets as a function of task or stimulus specific processing. Arch Sex Behav. 41(6):1389–1401.
   PubMed Web of Science ®Google Scholar
• Jacobsen FM. 1992. Fluoxetine-induced sexual dysfunction and an open trial of yohimbine. J Clin Psychiatry. 53:119–122.
   PubMed Web of Science ®Google Scholar
• Jacobsen NW, Hansen CH, Nellemann C, Styrishave B, Halling-Sørensen B. 2015. Effects of selective serotonin reuptake inhibitors on three sex steroids in two versions of the aromatase enzyme inhibition assay and in the H295R cell assay. Toxicol in Vitro. 29(7):1729–1735.
   PubMed Web of Science ®Google Scholar
• Jahnke S, Imhoff R, Hoyer J. 2015. Stigmatization of people with pedophilia: two comparative surveys. Arch Sex Behav. 44(1):21–34. 2015
   PubMed Web of Science ®Google Scholar
• Jakubczyk A, Krasowska A, Bugaj M, Kopera M, Klimkiewicz A, Łoczewska A, Michalska A, Majewska A, Szejko N, Podgórska A, et al. 2017. Paraphilic sexual offenders do not differ from control subjects with respect to dopamine- and serotonin-related genetic polymorphisms. J Sex Med. 14(1):125–133.
   PubMed Web of Science ®Google Scholar
• Jeffcoate WJ, Matthews RW, Edwards CR, Field LH, Besser GM. 1980. The effect of cyproterone acetate on serum testosterone, LH, FSH and prolactin in male sexual offenders. Clin Endocrinol. 13(2):189–195.
   PubMed Web of Science ®Google Scholar
• Jespersen AF, Lalumière ML, Seto MC. 2009. Sexual abuse history among adult sex offenders and non-sex offenders: a meta-analysis. Child Abuse Negl. 33(3):179–192.
   PubMed Web of Science ®Google Scholar
• Johnson RS, Ostermeyer B, Sikes KA, Nelsen AJ, Coverdale JH. 2014. Prevalence and treatment of frotteurism in the community: a systematic review. J Am Acad Psychiatry Law. 42(4):478–483.
   PubMed Web of Science ®Google Scholar
• Johnstone T. 1913. Lectures on clinical psychiatry by Dr. Emil Kraeplin. 3rd ed. London: Bailliere, Tindall, and Cox.
   Google Scholar
• Jordan K, Fromberger P, Laubinger H, Dechent P, Müller JL. 2014. Changed processing of visual sexual stimuli under GnRH-therapy–a single case study in pedophilia using eye tracking and fMRI. BMC Psychiatry 14(1):142.
   PubMed Web of Science ®Google Scholar
• Jordan K, Fromberger P, Stolpmann G, Müller JL. 2011. The role of testosterone in sexuality and paraphilia: a neurobiological approach. Part 1. testosterone and sexuality. J Sex Med. 8(11):2993–3007.
   PubMed Web of Science ®Google Scholar
• Kadar T, Telegdy G, Schally AV. 1992. Behavioral effects of centrally administered LH-RH agonist in rats. Physiol Behav. 50:601–605.
   Web of Science ®Google Scholar
• Kafka MP. 1991. Successful treatment of paraphilic coercive disorder (a rapist) with fluoxetine hydrochloride. Br J Psychiatry. 158(6):844–847.
   PubMed Web of Science ®Google Scholar
• Kafka MP. 1994. Sertraline pharmacotherapy for paraphilias and paraphilia-related disorders: an open trial. Ann Clin Psychiatry. 6(3):189–195.
   PubMedGoogle Scholar
• Kafka MP. 2006. The monoamine hypothesis for the pathophysiology of paraphilic disorders: an update. Ann NY Acad Sci. 989(1):86–94.
   Google Scholar
• Kafka MP. 2010. Hypersexual disorder: a proposed diagnosis for DSM-V. Arch Sex Behav. 39(2):377–400.
   PubMed Web of Science ®Google Scholar
• Kafka MP, Coleman E. 1991. Serotonin and paraphilias: the convergence of mood, impulse, and compulsive disorders. J Clin Psychopharmacol. 11(3):223–224.
   PubMed Web of Science ®Google Scholar
• Kafka MP, Hennen J. 1999. The paraphilia-related disorders: an empirical investigation of nonparaphilic hypersexuality disorders in outpatient males. J Sex Marital Ther. 25(4):305–319.
   PubMed Web of Science ®Google Scholar
• Kafka MP, Hennen J. 2000. Psychostimulant augmentation during treatment with selective serotonin reuptake inhibitors in men with paraphilias and paraphilia-related disorders: a case series. J Clin Psychiatry. 61(9):664–670.
   PubMed Web of Science ®Google Scholar
• Kafka MP, Hennen J. 2002. A DSM-IV Axis I comorbidity study of males (n = 120) with paraphilias and paraphilia-related disorders. Sex Abuse. 14(4):349–366.
   PubMedGoogle Scholar
• Kafka MP, Hennen J. 2003. Hypersexual desire in males: are males with paraphilias different from males with paraphilia-related disorders? Sex Abuse. 15(4):307–321.
   PubMedGoogle Scholar
• Kafka MP, Prentky R. 1992a. A comparative study of nonparaphilic sexual addictions and paraphilias in men. J Clin Psychiatry. 53:345–350.
   PubMed Web of Science ®Google Scholar
• Kafka MP, Prentky R. 1992b. Fluoxetine treatment of nonparaphilic sexual addictions and paraphilias in men. J Clin Psychiatry. 53(10):351–358.
   PubMed Web of Science ®Google Scholar
• Kafka MP, Prentky R. 1998. Attention-deficit/hyperactivity disorder in males with paraphilias and paraphilia-related disorders: a comorbidity study. J Clin Psychiatry. 59(7):388–396.
   PubMed Web of Science ®Google Scholar
• Kärgel C, Massau C, Weiß S, Walter M, Borchardt V, Krueger TH, Tenbergen G, Kneer J, Wittfoth M, Pohl A, et al. 2017. Evidence for superior neurobiological and behavioral inhibitory control abilities in non-offending as compared to offending pedophiles. Hum Brain Mapp. 38(2):1092–1104.
   PubMed Web of Science ®Google Scholar
• Kärgel C, Massau C, Weiß S, Walter M, Kruger THC, Schiffer B. 2015. Diminished functional connectivity on the road to child sexual abuse in pedophilia. J Sex Med. 12(3):783–795.
   PubMed Web of Science ®Google Scholar
• Kasper P. 2001. Cyproterone acetate: a genotoxic carcinogen? Pharmacol Toxicol. 88(5):223–231.
   PubMedGoogle Scholar
• Kendrick KM, Dixson AF. 1985. Luteinizing hormone releasing hormone enhances proceptivity in a primate. Neuroendocrinology, 41(6):449–53.
   Google Scholar
• Kenworthy T, Adams CE, Bilby C, Brooks-Gordon B, Fenton M. 2004. Psychological interventions for those who have sexually offended or are at risk of offending. Cochrane Database Syst Rev. 3:CD 004858.
   Google Scholar
• Kernberg OF. 1991. Sadomasochism, sexual excitement, and perversion. J Am Psychoanal Assoc. 39(2):333–362.
   PubMed Web of Science ®Google Scholar
• Khan O, Ferriter M, Huband N, Powney MJ, Dennis JA, Duggan C. 2015. Pharmacological interventions for those who have sexually offended or are at risk of offending. Cochrane Database Syst Rev. (2):CD007989.
   PubMed Web of Science ®Google Scholar
• Khazaal Y, Zullino DF. 2006. Topiramate in the treatment of compulsive sexual behavior: case report. BMC Psychiatry. 6(1):22.
   PubMed Web of Science ®Google Scholar
• Kiersch TA. 1990. Treatment of sex offenders with Depo Provera. Bull Am Acad Psychiatry Law. 18:179–187.
   PubMedGoogle Scholar
• King M, Bartlett A. 1999. British psychiatry and homosexuality. Br J Psychiatry. 175(2):106–113.
   PubMed Web of Science ®Google Scholar
• Kingston DA, Bradford JM. 2013. Hypersexuality and recidivism among sexual offenders. Sexual addiction & compulsivity. J Treat Prevent. 20(1–2):91–105.
   Google Scholar
• Kingston DA, Seto MC, Ahmed AG, Fedoroff P, Firestone P, Bradford JM. 2012. The role of central and peripheral hormones in sexual and violent recidivism in sex offenders. J Am Acad Psychiatry Law. 40(4):476–485.
   PubMed Web of Science ®Google Scholar
• Kingston DA, Seto MC, Firestone P, Bradford JM. 2010. Comparing indicators of sexual sadism as predictors of recidivism among adult male sexual offenders. J Consult Clin Psychol. 78(4):574–584.
   PubMed Web of Science ®Google Scholar
• Kirenskaya-Berus AV, Tkachenko AA. 2003. Characteristic features of EEG spectral characteristics in persons with deviant sexual behavior. Hum Physiol. 29(3):278–232.
   Google Scholar
• Knott V, Impey D, Fisher D, Delpero E, Fedoroff JP. 2016. Pedophilic brain potential responses to adult erotic stimuli. Brain Res. 1632:127–140.
   PubMed Web of Science ®Google Scholar
• Kogan BM, Tkachenko AA, Drozdov AZ, Andrianova EP, Filatova TS, Mankovskaya IV, Kovaleva JA. 1995. Monoamine metabolism in different forms of paraphilia. J Neurol Psychiatry Im SS Korsakova. 95(6):52–56.
   Google Scholar
• Koo KC, Ahn JH, Hong SJ, Lee JW, Chung BH. 2014. Effects of chemical castration on sex offenders in relation to the kinetics of serum testosterone recovery: implications for dosing schedule. J Sex Med. 11(5):1316–1324.
   PubMed Web of Science ®Google Scholar
• Krafft-Ebing R. v. 1886. Psychopathia sexualis. (Trans. Klaf FS, 1965). London: Staples Press.
   Google Scholar
• Kraus C, Hill A, Haberman N, Strohm K, Berner W, Briken P. 2006. Selective serotonin reuptake inhibitors (SSRIs) in the treatment of paraphilia. A retrospective study. Forstchr Neurol Psychiatry. 74:1–6.
   Google Scholar
• Kraus C, Strohm K, Hill A, Habermann N, Berner W, Briken P. 2007. Selective serotonin reuptake inhibitors (SSRI) in the treatment of paraphilia. Fortschr Neurol Psychiatr. 75(6):351–356.
   PubMed Web of Science ®Google Scholar
• Kravitz HM, Haywood TW, Kelly J, Liles S, Cavanaugh JL. 1996. Medroxyprogesterone and paraphiles: do testosterone levels matter? Bull Am Acad Psychiatry Law. 24(1):73–83.
   PubMedGoogle Scholar
• Kravitz HM, Haywood TW, Kelly J, Wahlstrom C, Liles S, Cavanaugh JL. 1995. Medroxyprogesterone treatment for paraphiliacs. Bull Am Acad Psychiatry Law. 23(1):19–33.
   PubMedGoogle Scholar
• Krueger RB, Hembree W, Hill M. 2006. Prescription of medroxyprogesterone acetate to a patient with pedophilia, resulting in Cushing’s syndrome and adrenal insufficiency. Sex Abuse. 18(2):227–228.
   PubMed Web of Science ®Google Scholar
• Krueger RB, Kaplan MS. 2000. Disorders of sexual impulse control in neuropsychiatric conditions. Semin Clin Neuropsychiatry. 5(4):266–274.
   PubMedGoogle Scholar
• Krueger RB, Kaplan MS. 2001. Depot-leuprolide acetate for treatment of paraphilias: a report of twelve cases. Arch Sex Behav. 30(4):409–422.
   PubMed Web of Science ®Google Scholar
• Krueger RB, Reed GM, First MB, Marais A, Kismodi E, Briken P. 2017. Proposals for paraphilic disorders in the international classification of diseases and related health problems, rleventh revision (ICD-11). Arch Sex Behav. 46(5):1529–1545.
   PubMed Web of Science ®Google Scholar
• Kruesi M, Fine S, Valladares L, Phillips RA, Rapoport J. 1992. Paraphilias: a double-blind cross-over comparison of clomipramine versus desipramine. Arch Sex Behav. 21(6):587–593.
   PubMed Web of Science ®Google Scholar
• Kruger THC, Sinke C, Kneer J, Tenbergen G, Khan AQ, Burkert A, Müller-Engling L, Engler H, Gerwinn H, von Wurmb-Schwark N, et al. 2019. Child sexual offenders show prenatal and epigenetic alterations of the androgen system. Transl Psychiatry. 9(1):28..
   PubMed Web of Science ®Google Scholar
• Lamy S, Delavenne H, Thibaut F. 2016. A case of female hypersexuality and child abuse and a review. Arch Womens Ment Health. 19(4):701–703.
   PubMed Web of Science ®Google Scholar
• Langeluddeke A. 1963. Castration of sexual criminals. Berlin, Germany: De Gruyter.
   Google Scholar
• Langevin R. 2006. Sexual offenses and traumatic brain injury. Brain Cogn. 60(2):206–207.
   PubMed Web of Science ®Google Scholar
• Langevin R, Wortzman G, Wright P, Handy L. 1989. Studies of brain damage and dysfunction in sex offenders. Sex Abuse. 2(2):163–179.
   Google Scholar
• Langevin R, Paitich D, Hucker S, Newman S, Ramsay G, Pope S, Geller G, Anderson C. 1979. The effect of assertiveness training, Provera and sex of therapist in the treatment of genital exhibitionism. J Behav Ther Exp Psychiatry. 10(4):275–282.
   Web of Science ®Google Scholar
• Långström N, Seto MC. 2006. Exhibitionistic and voyeuristic behavior in a Swedish national population survey. Arch Sex Behav. 35(4):427–435.
   PubMed Web of Science ®Google Scholar
• Laron Z, Kauli R. 2000. Experience with the cyproterone acetate in the treatment of precocious puberty. J Pediatr Endocrinol Metab. 13(S1):805–810.
   PubMed Web of Science ®Google Scholar
• Larue D, Schmidt AF, Imhoff R, Eggers K, Schönbrodt FD, Banse R. 2014. Validation of direct and indirect measures of preference for sexualized violence. Psychol Assessment. 26(4):1173–1183.
   PubMed Web of Science ®Google Scholar
• Laschet U, Laschet L. 1975. Antiandrogens in the treatment of sexual deviations of men. J Steroid Biochem. 6(6):821–826.
   PubMedGoogle Scholar
• Laschet U, Laschet L. 1967. Antiandrogen treatment of pathologically increased and abnormal sexuality in men. Klein Wochenschr. 45(6):324–325.
   PubMedGoogle Scholar
• Laschet U, Laschet L. 1971. Psychopharmacotherapy of sex offenders with cyproterone acetate. Pharmacopsychiatr Neuropsychopharmacol Adv Clin Res. 4(2):99–110.
   Google Scholar
• Laws DR, O’Donohue W. 1997. Introduction: fundamental issues in sexual deviance. In: Laws, DR and O’Donohue W, editor. Sexual deviance: theory, assessment and treatment. London: Guilford Press; p. 1–21.
   Google Scholar
• Lederer J. 1974. Treatment of sex deviations with cyproterone acetate. Probl Actuels Endocrinol Nutr. 18:249–260.
   PubMedGoogle Scholar
• Lehne GK. 1984. Brain damage and paraphilia treated with medroxyprogesterone acetate. Sex Disabil. 7(3–4):145–158.
   Google Scholar
• Leo RJ, Kim KY. 1995. Clomipramine treatment of paraphilias in elderly demented patients. J Geriatr Psychiatry Neurol. 8(2):123–124.
   PubMed Web of Science ®Google Scholar
• Leonard LM, Follette VM. 2002. Sexual functioning in women reporting a history of child sexual abuse: review of the empirical literature and clinical implications. Annu Rev Sex Res. 13:346–388.
   PubMedGoogle Scholar
• Levenson JS, Willis GM, Vicencio CP. 2017. Obstacles to help-seeking for sexual offenders: implications for prevention of sexual abuse. J Child Sex Abus. 26(2):99–120.
   PubMed Web of Science ®Google Scholar
• Light SA, Holroyd S. 2006. The use of medroxyprogesterone acetate for the treatment of sexually inappropriate behaviour in patients with dementia. J Psychiatry Neurosci. 31(2):132–134.
   PubMed Web of Science ®Google Scholar
• Lindsay WR, Smith AH, Law J, Quinn K, Anderson A, Smith A, Allan R. 2004. Sexual and nonsexual offenders with intellectual and learning disabilities: a comparison of characteristics, referral patterns, and outcome. J Interpers Violence. 19(8):875–890.
   PubMed Web of Science ®Google Scholar
• Lippi G, Van Staden PJ. 2017. The use of cyproterone acetate in a forensic psychiatric cohort of male sex offenders and its associations with sexual activity and sexual functioning. S Afr J Psychiat. 23:982. eCollection 2017.
   PubMed Web of Science ®Google Scholar
• Loosen PT, Purdon SE, Pavlou SN. 1994. Effects on behavior of modulation of gonadal function in men with gonadotrophin-releasing hormone antagonists. Am J Psychiatry. 151:271–273.
   PubMed Web of Science ®Google Scholar
• Lorefice LS. 1991. Fluoxetine treatment of a fetish. J Clin Psychiatry. 52(1):41.
   PubMed Web of Science ®Google Scholar
• Lorrain DS, Riolo JV, Matuszewich L, Hull EM. 1999. Lateral hypothalamic serotonin inhibits nucleus accumbens dopamine: implications for sexual satiety. J Neurosci. 19(17):7648–7652.
   PubMed Web of Science ®Google Scholar
• Losel F, Schmucker M. 2005. The effectiveness of treatment for sexual offenders: a comprehensive meta-analysis. J Exp Criminol. 1(1):117–146.
   Google Scholar
• Maes M, van WD, De Vos N, Westenberg H, Van HF, Hendriks D, Cosyns P, Scharpé S. 2001. Lower baseline plasma cortisol and prolactin together with increased body temperature and higher mCPP-induced cortisol responses in men with pedophilia. Neuropsychopharmacology. 24(1):37–46.
   PubMed Web of Science ®Google Scholar
• Maletzky BM, Steinhauser C. 2002. A 25-year follow up of cognitive-behavioral therapy with 7275 sexual offenders. Behav Modif. 26(2):123–147.
   PubMed Web of Science ®Google Scholar
• Maletzky BM, Tolan A, McFarland B. 2006. The Oregon Depo-Provera program: a five-year follow-up. Sex Abuse. 18(3):303–316.
   PubMed Web of Science ®Google Scholar
• Malin HM, Saleh FM. 2007. Paraphilias: clinical and forensic considerations. Psychiatric Times. 24(5):1–4.
   Google Scholar
• Mann RE, Hanson RK, Thornton D. 2010. Assessing risk for sexual recidivism: some proposals on the nature of psychologically meaningful risk factors. Sex Abuse. 22(2):191–217.
   PubMed Web of Science ®Google Scholar
• Marazziti D, Baroni S, Masala I, Golia F, Consoli G, Massimetti G, Picchetti M, Catena M, Dell’Osso Giannaccini G, Betti L, et al. 2010. Impulsivity, gender, and the platelet serotonin transporter in healthy subjects. Neuropsychiatr Dis Treat. 6:9–15.
   PubMed Web of Science ®Google Scholar
• Marques JK, Day DM, Nelson C, West MA. 1994. Effects of cognitive-behavioural treatment on sex offender recidivism. Crim Justice Behav. 21(1):28–54.
   Web of Science ®Google Scholar
• Marques JK, Wiederanders M, Day DM, Nelson C, Van Ommeren A. 2005. Effects of a relapse prevention program on sexual recidivism: final results from California’s sex offender treatment and evaluation project (SOTEP). Sex Abuse. 17(1):79–107.
   PubMed Web of Science ®Google Scholar
• Marshall P. 1997. The prevalence of convictions for sexual offending. Home office research and statistics directorate research findings. 55th ed. London: Home Office.
   Google Scholar
• Marshall WL. 2006. Diagnostic problems with sexual offenders. In: Marshall WL, Fernandez YM, Marshall LE and Serran GA, editors. Sexual offender treatment: controversial issues. Chichester, England: Wiley; p. 33–43.
   Google Scholar
• Marshall WL. 2014. Phallometric assessments of sexual interests: an update. Curr Psychiatry Rep. 16(1):428–234.
   PubMed Web of Science ®Google Scholar
• Marshall WL, Barbaree HE. 1990. Outcome of comprehensive cognitive-behavioral treatment programs. In: Marshall WL, Laws DR, Barbaree HE, editors. Handbook of sexual assault: issues, theories, and treatment of the offenders. New York (NY): Plenum Press; p. 363–385.
   Google Scholar
• Marshall WL, Fernandez YM. 2000. Phallometric testing with sexual offenders: limits to its value. Clin Psychol Rev. 20(7):807–822.
   PubMed Web of Science ®Google Scholar
• Marshall WL, Marshall LE. 2007. The utility of the random controlled trial for evaluating sexual offender treatment: the gold standard or an inappropriate strategy? Sex Abuse. 19(2):175–191.
   PubMed Web of Science ®Google Scholar
• Marshall WL, Serran GA, Cortoni FA. 2000. Childhood attachments, sexual abuse, and their relationship to adult coping in child molesters. Sex Abuse. 12(1):17–26.
   PubMedGoogle Scholar
• Marshall WA, Tanner JM. 1970. Variations in the pattern of pubertal changes in boys. Arch Dis Child. 45(239):13–23.
   PubMed Web of Science ®Google Scholar
• Marshall WL, Ward T, Mann RE, Moulden H, Fernandez YM, Serran G, Marshall LE. 2005. Working positively with sexual offenders: maximizing the effectiveness of treatment. J Interpers Violence. 20(9):1096–1114.
   PubMed Web of Science ®Google Scholar
• Mayrhofer G, Voß T, Wegner D. 2016. Urolithiasis in the long-term GnRH agonist treatment of patients with paraphilia: three case studies. Aktuelle Urol. 47(6):487–490.
   PubMed Web of Science ®Google Scholar
• McAnulty RD, Adams HE. 1992. Validity and ethics of penile circumference measures of sexual arousal: A reply to McConaghy. Arch Sex Behav. 21(2):177–86; discussion 187–95.
   PubMed Web of Science ®Google Scholar
• McConaghy N. 1998. Paedophilia: a review of the evidence. Aust N Z J Psychiatry. 32:252–265.
   PubMed Web of Science ®Google Scholar
• McConaghy N, Blaszczynski A, Armstrong MS, Kidson W. 1989. Resistance to treatment of adolescent sex offenders. Arch Sex Behav. 18(2):97–107.
   PubMed Web of Science ®Google Scholar
• McEvoy G. 1999. AHFS drug information. Bethesda (MD): American Society of Health-System Pharmacists.
   Google Scholar
• McGrath R, Cumming G, Burchard B, Zeoli S, Ellerby L. 2010. Current practices and emerging trends in sexual abuser management: the safer society 2009 North American survey. Brandon (VT): Safer Society Press.
   Google Scholar
• Meijer EH, Verschuere B, Merckelbach HL, Crombez G. 2008. Sex offender management using the polygraph: a critical review. Int J Law Psychiatry. 31(5):423–429.
   PubMed Web of Science ®Google Scholar
• Melior CS, Farid NR, Craig DF. 1988. Female hypersexuality treated with cyproterone acetate. Am J Psychiatry. 145:1037.
   Web of Science ®Google Scholar
• Mellela JT, Travin S, Cullen K. 1989. Legal and ethical issues in the use of antiandrogens in treating sex offenders. Bull Am Acad Psychiatr Law. 17(3):223–232.
   PubMedGoogle Scholar
• Melnyk J, Thompson H, Rucci AJ, Vanasek F, Hayes S. 1969. Failure of transmission of the extra chromosome in subjects with 47,XYY karoytype. Lancet. 294(7624):797–798.
   Google Scholar
• Mendez MF, Chow T, Ringman J, Twitchell G, Hinkin CH. 2000. Pedophilia and temporal disturbances. J Neuropsychiatry Clin Neurosci. 12(1):71–76.
   PubMed Web of Science ®Google Scholar
• Meston CM, Frohlich PF. 2000. The neurobiology of sexual function. Arch Gen Psychiatry. 57(11):1012–1030.
   PubMed Web of Science ®Google Scholar
• Meyer JW, Cole CM. 1997. Physical and chemical castration of sex offenders: a review. J Rehab. 25(3–4):1–18.
   Google Scholar
• Meyer WJ, Cole CM, Emory E. 1992. Depo provera treatment of sex offending behavior: an evaluation of outcome. Bull Am Acad Psychiatry Law. 20(3):249–259.
   PubMedGoogle Scholar
• Meyer WJ, Walker PA, Emory LE, Smith ER. 1985. Physical, metabolic, and hormonal effects on men of long-term therapy with medroxyprogesterone acetate. Fertil Steril. 43(1):102–109.
   PubMed Web of Science ®Google Scholar
• Meyer WJ, Wiener I, Emory LE, Cole CM, Isenberg N, Fagan CJ, Thompson JC. 1992. Cholelithiasis associated with medroxyprogesterone acetate in therapy with men. Res Commun Chem Pathol Pharmacol. 75(1):69–84.
   PubMedGoogle Scholar
• Mincke E, Cosyns P, Christophe AB, De Vriese S, Maes M. 2006. Lower omega-3 polyunsaturated fatty acids and lower docosahexaenoic acid in men with pedophilia. Neuroendocrinol Lett. 27(6):719–723.
   PubMed Web of Science ®Google Scholar
• Mitchell W, Falconer MA, Hill D. 1954. Epilepsy with fetishism relieved by temporal lobectomy. Lancet. 264(6839):626–630.
   Google Scholar
• Mohnke S, Müller S, Amelung T, Krüger THC, Ponseti J, Schiffer B, Walter M, Beier KM, Walter H. 2014. Brain alterations in paedophilia: a critical review. Prog Neurobiol. 122:1–23.
   PubMed Web of Science ®Google Scholar
• Mokros A, Osterheider M, Nitschke J. 2012. Pedophilia. Prevalence, etiology, and diagnostics. Nervenarzt. 83(3):355–358.
   PubMed Web of Science ®Google Scholar
• Money J. 1968. Discussion on hormonal inhibition of libido in male sex offenders. In: Michael RP, editor. Endocrinology and human behavior. London: Oxford University Press; p. 169.
   Google Scholar
• Money J. 1986. Lovemaps: clinical concepts of sexual/erotic health and pathology, paraphilia, and gender transposition in childhood, adolescence and maturity. New York (NY): Irvington; Prometheus Books.
   Google Scholar
• Money J. 1990. Forensic sexology: paraphilic serial rape (biastophilia) and lust murder (erotophonophilia). Am J Psychother. 44(1):26–36.
   PubMed Web of Science ®Google Scholar
• Money J, Bennett RG, Cameron WR. 1981. Postadolescent paraphiliac sex offenders: hormonal and counseling therapy follow up. Int J Ment Health. 10(2–3):122–133.
   Web of Science ®Google Scholar
• Money J, Wiedeking C, Walker P, Migeon C, Meyer W, Borgaonkar D. 1975. XYY and 46, XY males with antisocial and/or sex offending behavior: antiandrogen therapy plus counselling. Psychoneuroendocrinology. 1(2):165–178.
   PubMed Web of Science ®Google Scholar
• Montejo AI, Llorca G, Izquierdo JA, Ledesma A, Bousono M, Calcedo A. 1996. Sexual dysfunction secondary to SSRIs. A comparative analysis in 308 patients. Actas Luso Esp Neurol Psiquiatr Cienc Afines. 24(6):311–321.
   PubMedGoogle Scholar
• Morrison T, Erooga M, Beckett RL. 1994. Adult sex offenders: who are they? Why and how do they do it? Sexual offending against children: assessment and treatment of male abusers. London: Routledge; p. 1–24.
   Google Scholar
• Moss RL, Dudley CA. 1989. Luteinizing hormone-releasing hormone (LHRH) peptidergic signals in the neural integration of female reproductive behavior. In: Lakoski JM, Perez-Polo JR, Rassin DK, editors. Neural control of reproductive function. New York (NY): Liss; p. 485–499.
   Google Scholar
• Mothes B, Lehnert J, Samimi, Ufer J. 1971. Klinishe Prüfung von cyproteronacetat bei sexualdeviationen gesamtauswertung. In: Raspe G, editor. Schering symposium über sexualdeviationen und ihre medikamentöse behandlung. Oxford: Pergamon Press; p. 65–87.
   Google Scholar
• Moulden HM, Firestone P, Kingston D, Bradford J. 2009. Recidivism in pedophiles: an investigation using different diagnostic methods. J Forens Psychiatry Psychol. 20(5):680–701.
   Web of Science ®Google Scholar
• Moulier V, Fonteille V, Pelegrini-Issac M, Cordier B, Baron-Laforêt S, Boriasse E, Durand E, Stolérru S. 2012. A pilot study of the effects of gonadotropin-releasing hormone agonist therapy on brain activation pattern in a man with pedophilia. Int J Offender Ther Comp Criminol. 56(1):50–60.
   PubMed Web of Science ®Google Scholar
• Müller K, Curry S, Ranger R, Briken P, Bradford J, Fedoroff JP. 2014. Changes in sexual arousal as measured by penile plethysmography in men with pedophilic sexual interest. J Sex Med. 11(5):1221–1229.
   PubMed Web of Science ®Google Scholar
• Murphy L, Bradford JB, Fedoroff JP. 2014. Paraphilia and paraphilic disorders. In: Gabbard GO, editor. Gabbard’s treatments of psychiatric disorders. Washington (DC): American Psychiatric Publishing; p. 669–694.
   Google Scholar
• Murphy L, Ranger R, Stewart H, Dwyer G, Fedoroff JP. 2015. Assessment of problematic sexual interests with the penile plethysmograph: an overview of assessment laboratories. Curr Psychiatry Rep. 17(5):29.
   PubMed Web of Science ®Google Scholar
• Murray JB. 2000. Psychological profile of pedophiles and child molesters. J Psychol. 134(2):211–224.
   PubMed Web of Science ®Google Scholar
• Nelson E, Brusman L, Holcomb J, Soutullo C, Beckman D, Welge JA, Kuppili N, McElroy SL. 2001. Divalproex sodium in sex offenders with bipolar disorders and comorbid paraphilias: an open retrospective study. J Affect Disord. 64(2–3):249–255.
   PubMed Web of Science ®Google Scholar
• Neuman F. 1977. Pharmacology and potential use of cyproterone acetate. Horm Metab Res. 9:1–13.
   PubMed Web of Science ®Google Scholar
• Neumann I, Thierau D, Andrae U, Greim H, Schwarz LR. 1992. Cyproterone acetate induces DNA damage in cultured rat hepatocytes and preferentially stimulates DNA synthesis in gamma-glutamyltranspeptidase-positive cells. Carcinogenesis. 13(3):373–378.
   PubMed Web of Science ®Google Scholar
• Neutze J, Grundmann D, Scherner G, Beier KM. 2012. Undetected and detected child sexual abuse and child pornography offenders. Int J Law Psychiatry. 35(3):168–175.
   PubMed Web of Science ®Google Scholar
• Nitschke J, Osterheider M, Mokros A. 2009. A cumulative scale of severe sexual sadism. Sex Abuse. 21(3):262–278.
   PubMed Web of Science ®Google Scholar
• No Authors Listed 2014. Atypical neuroleptics: compulsive disorders. Prescrire Int. 23(146):43–44.
   PubMedGoogle Scholar
• Nota NM, Wiepjes CM, de Blok CJM, Gooren LJG, Peerdeman SM, Kreukels BPC, den Heijer M. 2018. The occurrence of benign brain tumours in transgender individuals during cross-sex hormone treatment. Brain. 141(7):2047–2054.
   PubMed Web of Science ®Google Scholar
• Nunes KL, Hermann CA, Renee Malcom J, Lavoie K. 2013. Childhood sexual victimization, pedophilic interest, and sexual recidivism. Child Abuse Negl. 37(9):703–711.
   PubMed Web of Science ®Google Scholar
• O’Donovan R ,Völlm B. 2018. Klinefelter’s syndrome and sexual offending: a review of the literature. Crim Behav Ment Health. 28(2):132–140.
   PubMed Web of Science ®Google Scholar
• Olsson H, Petri N, Erichsen L, Malmberg A, Grundemar L. 2017. Effect of degarelix, a gonadotropin-releasing hormone receptor antagonist for the treatment of prostate cancer, on cardiac repolarisation in a randomised, placebo and active comparator-controlled thorough QT/QTc trial in healthy men. Clin Drug Investig. 37(9):873–879.
   PubMed Web of Science ®Google Scholar
• Olver ME, Mundt JC, Thornton D, Beggs Christofferson SM, Kingston DA, Sowden JN, Nicholaichuk TP, Gordon A, Wong S. 2018. Using the violence risk scale-sexual offense version in sexual violence risk assessments: updated risk categories and recidivism estimates from a multisite sample of treated sexual offenders. Psychol Assess. 30(7):941–955.
   PubMed Web of Science ®Google Scholar
• Olver ME, Neumann CS, Kingston DA, Nicholaichuk TP, Wong S. 2018. Construct validity of the violence risk scale-sexual offender version instrument in a multisite sample of treated sexual offenders. Assessment. 25(1):40–55.
   PubMed Web of Science ®Google Scholar
• Olver ME, Sowden JN, Kingston DA, Nicholaichuk TP, Gordon A, Beggs Christofferson SM, Wong S. 2018. Predictive accuracy of violence risk scale-sexual offender version risk and change scores in treated Canadian aboriginal and non-aboriginal sexual offenders. Sex Abuse. 30(3):254–275.
   PubMed Web of Science ®Google Scholar
• Ortmann J. 1980. The treatment of sexual offenders: castration and antihormone therapy. Int J Law Psychiatry. 3(4):443–451.
   PubMed Web of Science ®Google Scholar
• Ott BR. 1995. Leuprolide treatment of sexual aggression in a patient with dementia and the Klüver-Bucy syndrome. Clin Neuropharmacol. 18(5):443–447.
   PubMed Web of Science ®Google Scholar
• Ozkan B, Wilkins K, Muralee S, Tampi RR. 2008. Pharmacotherapy for inappropriate sexual behaviors in dementia: a systematic review of literature. Am J Alzheimers Dis Other Demen. 23(4):344–354.
   PubMed Web of Science ®Google Scholar
• Panesar N, Allard B, Pai N, Valachova I. 2011. Cyproterone acetate in paraphilia. Aust N Z J Psychiatry. 45(5):428–428.
   PubMed Web of Science ®Google Scholar
• Park WS, Kim KM, Jung YW, Lim MH. 2014. A case of mental retardation with para- philia treated with depot leuprorelin. J Korean Med Sci. 29(9):1320–1324.
   PubMed Web of Science ®Google Scholar
• Patra AP, Bharadwaj B, Shaha KK, Das S, Rayamane AP, Tripathi CS. 2013. Impulsive frotteurism: a case report. Med Sci Law. 53(4):235–238.
   PubMed Web of Science ®Google Scholar
• Pearson HJ. 1990. Paraphilias, impulse control and serotonin. J Clin Psychopharmacol. 10:133–134.
   PubMed Web of Science ®Google Scholar
• Perilstein R, Lipper S, Friedman LJ. 1991. Three cases of paraphilias responsive to fluoxetine treatment. J Clin Psychiatry. 52(4):169–170.
   PubMed Web of Science ®Google Scholar
• Pfeiffer D. 1994. Eugenics and disability discrimination. Disabil Soc. 9(4):481–499.
   Web of Science ®Google Scholar
• Pithers WD, Becker JV, Kafka M, Morentz B, Schalnk A, Leombruno T. 1995. Children with sexual behavior problems, adolescent sexual abusers and adult sex offenders: assessment and treatment. Int Rev Psychiatry. 14:779–818.
   Google Scholar
• Poeppl TB, Langguth B, Laird AR, Eickhoff SB. 2014. The functional neuroanatomy of male psychosexual and physiosexual arousal: a quantitative meta-analysis. Hum Brain Mapp. 35(4):1404–1421.
   PubMed Web of Science ®Google Scholar
• Poeppl TB, Langguth B, Rupprecht R, Laird AR, Eickhoff SB. 2016. A neural circuit encoding sexual preference in humans. Neurosci Biobehav Rev. 68:530–536.
   PubMed Web of Science ®Google Scholar
• Poeppl TB, Nitschke J, Dombert B, Santtila P, Greenlee MW, Osterheider M, Mokros A. 2011. Functional cortical and subcortical abnormalities in pedophilia: a combined study using a choice reaction time task and fMRI. J Sex Med. 8(6):1660–1674.
   PubMed Web of Science ®Google Scholar
• Poeppl TB, Nitschke J, Santtila P, Schecklmann M, Langguth B, Greenlee MW, Osterheider M, Mokros A. 2013. Association between brain structure and phenotypic characteristics in pedophilia. J Psychiatr Res. 47(5):678–685.
   PubMed Web of Science ®Google Scholar
• Pohl A, Wolters A, Ponseti J. 2016. Investigating the task dependency of viewing time effects. J Sex Res. 53(8):1027–1035.
   PubMed Web of Science ®Google Scholar
• Polak MA, Nijman H. 2005. Pharmacological treatment of sexually aggressive forensic psychiatric patients. Psychol Crime Law. 11(4):457–465.
   Web of Science ®Google Scholar
• Ponseti J, Granert O, Jansen O, Wol S, Beier K, Neutze J. 2012. Assessment of pedophilia using hemodynamic brain response to sexual stimuli. Arch Gen Psychiatry. 69(2):187–194.
   PubMed Web of Science ®Google Scholar
• Prentky RA, Lee AFS, Knight RA, Cerce D. 1997. Recidivism rates among child molesters and rapists: a methodological analysis. Law Hum Behav. 21(6):635–659.
   PubMed Web of Science ®Google Scholar
• Radford JP, Park DC. 1996. The eugenic legacy. J Dev Disabil. 4(1):63–74.
   Google Scholar
• Raymond N, Coleman E, Ohlerking F. 1999. Psychiatric comorbidity in pedophilic sex offenders. Am J Psychiatry. 156:786–788.
   PubMed Web of Science ®Google Scholar
• Rea JA, Dixon MR, Zettle RD, Wright KL. 2017. The development of in vivo measures to assess the impact of sex-drive reducing medications in an offender with an intellectual disability. Arch Sex Behav. 46(3):843–859.
   PubMed Web of Science ®Google Scholar
• Reed GM, Drescher J, Krueger RB, Atalla E, Cochran SD, First MB, Cohen-Kettenis PT, Arango-de Montis I, Parish SJ, Cottler S, et al. 2016. Disorders related to sexuality and gender identity in the ICD-11: revising the ICD-10 classification based on current scientific evidence, best clinical practices, and human rights considerations. World Psychiatry. 15(3):205–221.
   PubMed Web of Science ®Google Scholar
• Reilly DR, Delva NJ, Hudson RW. 2000. Protocols for the use of cyproterone, medroxyprogesterone, and leuprolide in the treatment of paraphilia. Can J Psychiatry. 45(6):559–563.
   PubMed Web of Science ®Google Scholar
• Renaud P, Rouleau JL, Proulx J, Trottier D, Goyette M, Bradford JP, Fedoroff P, Dufresne MH, Dassylva B, Côté G, et al. 2010. Virtual characters designed for forensic assessment and rehabilitation of sex offenders: standardized and made-to-measure. J Virt Real Broadcast. 7(5).
   Google Scholar
• Rettenberger M, Rice ME, Harris GT, Eher R. 2017. Actuarial risk assessment of sexual offenders: the psychometric properties of the Sex Offender Risk Appraisal Guide (SORAG). Psychol Assess. 29(6):624–638.
   PubMed Web of Science ®Google Scholar
• Rich SS, Ovsiew F. 1994. Leuprolide acetate for exhibitionism in Huntington’s disease. Mov Disord. 9(3):353–357.
   PubMed Web of Science ®Google Scholar
• Roberts JV, Grossman MG. 1993. Sexual homicide in Canada: a descriptive analysis. Ann Sex Res. 6(1):5–25.
   Google Scholar
• Roeder FD. 1966. Stereotaxic lesion of the tuber cinerium in sexual deviation. Stereotact Funct Neurosurg. 27(1–3):162–163.
   Google Scholar
• Roeder FD, Orthner H, Muller D. 1972. The stereotaxic treatment of paedophilic homosexuality and other sexual deviations. In: Hitchcock L, Laitinen L, Vaernet K, editors. Psychosurgery. Springfield (IL): Ill. Thomas; p. 87–111.
   Google Scholar
• Romero JJ, Williams LM. 1983. Group psychotherapy and intensive probation supervision with sex offenders. Fed Probat. 47:36–42.
   Google Scholar
• Rosen I. 1997. Sexual deviation. 3rd ed. Oxford: Oxford University Press.
   Google Scholar
• Rösler A, Witztum E. 1998. Treatment of men with paraphilia with a long-acting analogue of gonadotropin-releasing hormone. N Engl J Med. 338(7):416–422.
   PubMed Web of Science ®Google Scholar
• Rösler A, Witztum E. 2000. Pharmacotherapy of paraphilias in the next millennium. Behav Sci Law. 18(1):43–56.
   PubMed Web of Science ®Google Scholar
• Rösler W. 2008. ENDO 2008: Endocrine Society’s 90th Annual Meeting; June 15–18; San Francisco, CA.
   Google Scholar
• Rosner R. 2003. Principles and practice of forensic psychiatry. 2nd ed. London: Arnold London Press; p. 686.
   Google Scholar
• Ross LA, Bland WP, Ruskin P, Bacher N. 1987. Antiandrogen treatment of aberrant sexual activity. Am J Psychiatry. 144(11):1511.
   PubMed Web of Science ®Google Scholar
• Rousseau L, Couture M, Dupont A, Labrie F, Couture N. 1990. Effect of combined androgen blockade with an LHRH agonist and flutamide in one severe case of male exhibitionism. Can J Psychiatry. 35(4):338–341.
   PubMed Web of Science ®Google Scholar
• Rubenstein EB, Engel NL. 1996. Successful treatment of transvestic fetishism with sertraline and lithium. J Clin Psychiatry. 57(2):92.
   PubMed Web of Science ®Google Scholar
• Rubinow DR, Schmidt PJ. 1996. Androgens, brain, and behavior. Am J Psychiatry. 153:974–984.
   PubMed Web of Science ®Google Scholar
• Ryback RS. 2004. Naltrexone in the treatment of adolescent sexual offenders. J Clin Psychiatry. 65(7):982–986.
   PubMed Web of Science ®Google Scholar
• Saleh F. 2005. A hypersexual paraphilic patient treated with leuprolide acetate: a single case report. J Sex Marital Ther. 31(5):433–444.
   PubMed Web of Science ®Google Scholar
• Saleh FM. 2004. Serotonin reuptake inhibitors and the paraphilias. Am Acad Psychiatry Law Newsletter. 29(3):12–13.
   Google Scholar
• Saleh FM, Niel T, Fishman MJ. 2004. Treatment of paraphilia in young adults with leuprolide acetate: a preliminary case report series. J Forensic Sci. 49(6):1–1348.
   Web of Science ®Google Scholar
• Salter D, McMillan D, Richards M, Talbot T, Hodges J, Bentovim A, Hastings R, Stevenson J, Skuse D. 2003. Development of sexually abusive behaviour in sexually victimised males: a longitudinal study. Lancet. 361(9356):471–476.
   PubMed Web of Science ®Google Scholar
• Sammet K. 2005. Risking more freedom? Cyproterone acetate, sexual offenders and the German “law on voluntary castration and other methods of treatment” 1960–1975. Medizinhist J. 40(1):51–78.
   PubMedGoogle Scholar
• Sanderson R. 1960. Clinical trial with Melleril* in the treatment of schizophrenia. J Ment Sci. 106:732–741.
   PubMed Web of Science ®Google Scholar
• Sartorius A, Ruf M, Kief C, Demirakca T, Bailer J, Ende G, Henn FA, Meyer-Lindenberg A, Dressing H. 2008. Abnormal amygdala activation profile in pedophilia. Eur Arch Psychiatry Clin Neurosc. 258(5):271–277.
   PubMed Web of Science ®Google Scholar
• Sauter J, Turner D, Briken P, Rettenberger M. 2020. Testosterone-lowering medication and its association with recidivism risk in individuals convicted of sexual offences. Sexual abuse. Advanced Online Publication.
   Google Scholar
• Schiffer B, Gizewski E, Kruger T. 2009. Reduced neuronal responsiveness to visual sexual stimuli in a pedophile treated with a long-acting LH-RH agonist. J Sex Med. 6(3):892–894.
   PubMed Web of Science ®Google Scholar
• Schiffer B, Krueger T, Paul T, de Greiff A, Forsting M, Leygraf N. 2008. Brain response to visual sexual stimuli in homosexual pedophiles. J Psychiatry Neurosci. 33:23–33.
   PubMed Web of Science ®Google Scholar
• Schiffer B, Peschel T, Paul T, Gizewski E, Forsting M, Leygraf N, Schedlowski M, Krueger TH. 2007. Structural brain abnormalities in the frontostriatal system and cerebellum in pedophilia. J Psychiatr Res. 41(9):753–762.
   PubMed Web of Science ®Google Scholar
• Schiffer B, Amelung T, Pohl A, Kaergel C, Tenbergen G, Gerwinn H, Mohnke S, Massau C, Matthias W, Weiß S, et al. 2017. Gray matter anomalies in pedophiles with and without a history of child sexual offending. Trans Psychiatry. 7(5):e1129–e1129.
   PubMed Web of Science ®Google Scholar
• Schiffer B, Paul T, Gizewski E, Forsting M, Leygraf N, Schedlowski M, Kruger THC. 2008. Functional brain correlates of heterosexual paedophilia. NeuroImage. 41(1):80–91.
   PubMed Web of Science ®Google Scholar
• Schiltz K, Witzel J, Northoff G, Zierhut K, Gubka U, Fellmann H, Kaufman J, Tempelmann C, Wiebking C, Bogerts B. 2007. Brain pathology in pedophilic offenders. Arch Gen Psychiatry. 64(6):737–746.
   PubMed Web of Science ®Google Scholar
• Schlesinger LB. 2004. Sexual murder: catathymic and compulsive homicides. London: CRC Press.
   Google Scholar
• Schmidt AF, Babchishin KM, Lehmann R. 2017. A meta-analysis of viewing time measures of sexual interest in children. Arch Sex Behav. 46(1):287–300.
   PubMed Web of Science ®Google Scholar
• Schmidt AF, Gykiere K, Vanhoeck K, Mann RE, Banse R. 2014. Direct and Indirect measures of sexual maturity preferences differentiate subtypes of child sexual abusers. Sex Abuse. 26(2):107–128.
   PubMed Web of Science ®Google Scholar
• Schmucker M, Lösel F. 2015. The effects of sexual offender treatment on recidivism: an international meta-analysis of sound quality evaluations. J Exp Criminol. 11(4):597–630.
   Web of Science ®Google Scholar
• Schober JM, Byrne P, Kuhn PJ. 2006. Leuprolide acetate is a familiar drug that may modify sex-offender behaviour: the urologist’s role. BJU Int. 97(4):684–686.
   PubMed Web of Science ®Google Scholar
• Schober JM, Kuhn PJ, Kovacs PG, Earle JH, Byrne PM, Fries RA. 2005. Leuprolide acetate suppresses pedophilic urges and arousability. Arch Sex Behav. 34(6):691–705.
   PubMed Web of Science ®Google Scholar
• Seifert D, Moller-Mussavi S, Wirtz M. 2005. Risk assessment of sexual offenders in German forensic institutions. Int J Law Psychiatry. 28(6):650–660.
   PubMed Web of Science ®Google Scholar
• Seto MC. 2008. Pedophilia and sexual offending against children: theory, assessment, and intervention. Washington (DC): American Psychological Association.
   Google Scholar
• Seto MC, Cantor JM, Blanchard R. 2006. Child pornography offenses are a valid diagnostic indicator of pedophilia. J Abnorm Psychol. 115(3):610–615.
   PubMed Web of Science ®Google Scholar
• Seto MC, Fedoroff JP, Bradford JM, Knack N, Rodrigues NC, Curry S, Booth B, Gray J, Cameron C, Bourget D, et al. 2016. Reliability and validity of the DSM-IV-TR and proposed DSM-5 criteria for pedophilia: Implications for the ICD-11 and the next DSM. Int J Law Psychiatry. 49:98–106.
   PubMed Web of Science ®Google Scholar
• Seto MC, Fedoroff JP, Bradford JMW, Knack N, Rodrigues NC, Curry S, Booth B, Gray J, Cameron C, Bourget D, et al. 2009. Pedophilia. Annu Rev Clin Psychol. 5:391–407.
   PubMed Web of Science ®Google Scholar
• Seto MC, Hermann CA, Kjellgren C, Priebe G, Svedin CG, Långström N. 2015. Viewing child pornography: prevalence and correlates in a representative community sample of young Swedish men. Arch Sex Behav. 44(1):67–79.
   PubMed Web of Science ®Google Scholar
• Sherak DL. 2000. Pharmacological treatment of sexually offending behavior in people with mental retardation/developmental disabilities. Ment Health Asp Dev Disabil. 3(2):62–74.
   Google Scholar
• Shiah IS, Chao CY, Mao WC, Chuang YJ. 2006. Treatment of paraphilic sexual disorder: the use of topiramate in fetishism. Int Clin Psychopharmacol. 21:241–243.
   PubMed Web of Science ®Google Scholar
• Simpson G, Blaszczynski A, Hodgkinson A. 1999. Sex offending as a psychosocial sequela of traumatic brain injury. J Head Trauma Rehabil. 14(6):567–580.
   PubMed Web of Science ®Google Scholar
• Smith AD, Taylor PJ. 1999. Serious sex offending against women by men with schizophrenia: relationship of illness and psychotic symptoms to offending. Br J Psychiatry. 174(3):233–237.
   PubMed Web of Science ®Google Scholar
• Solla P, Bortolato M, Cannas A, Mulas CS, Marrosu F. 2015. Paraphilias and paraphilic disorders in Parkinson’s disease: a systematic review of the literature. Mov Disord. 30(5):604–613.
   PubMed Web of Science ®Google Scholar
• Soothill KL, Gibbens T. 1978. Recidivism of sexual offenders: reappraisal. Br J Criminol. 18(3):267–275.
   Web of Science ®Google Scholar
• Southren AL, Gordon GG, Vittek J, Altman K. 1977. Effect of progestagens on androgen metabolism. In: Martini L, Motta M, editors. Androgens and antiandrogens. New York (NY): Raven Press; p. 263–279.
   Google Scholar
• Sowden JN, Olver ME. 2017. Use of the violence risk scale-sexual offender version and the stable 2007 to assess dynamic sexual violence risk in a sample of treated sexual offenders. Psychol Assess. 29(3):293–303.
   PubMed Web of Science ®Google Scholar
• Soyka M, Kranzler HR, Berglund M, Gorelick D, Hesselbrock V, Johnson BA, Möller HJ. 2008. the WFSBP task force on treatment guidelines for substance use disorders. World J Biol Psychiatry. 9(1):6–23.
   PubMed Web of Science ®Google Scholar
• Stein DJ, Hollander E, Anthony DT, Schneier FR, Fallon BA, Liebowitz MR, Klein DF. 1992. Serotoninergic medications of sexual obsessions, sexual addictions, and paraphilias. J Clin Psychiatry. 53(8):267–271.
   PubMed Web of Science ®Google Scholar
• Štěpán JJ, Lachman M, Zvěřina JAN, Pacovský V, Baylink DJ. 1989. Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling. J Clin Endocrinol Metab. 69(3):523–590.
   PubMed Web of Science ®Google Scholar
• Stephens S, Cantor JM, Goodwill AM, Seto MC. 2017. Multiple indicators of sexual interest in prepubescent or pubescent children as predictors of sexual recidivism. J Consult Clin Psychol. 85(6):585–595.
   PubMed Web of Science ®Google Scholar
• Sterkman P, Geerts F. 1966. Is benperidol (RF 504) the specific drug for the treatment of excessive and disinhibited sexual behaviour? Acta Neurol Psychiatr (Belgique). 66:1030–1040.
   Google Scholar
• Steward JT, Shin KJ. 1997. Paroxetine treatment of sexual disinhibition in dementia. Am J Psychiatry. 154:1474.
   Web of Science ®Google Scholar
• Stewart JT. 2005. Optimizing antilibidinal treatment with medroxyprogesterone acetate. J Am Geriatr Soc. 53(2):359–360.
   PubMed Web of Science ®Google Scholar
• Stochholm K, Bojesen A, Jensen AS, Juul S, Gravholt CH. 2012. Criminality in men with Klinefelter’s syndrome and XYY syndrome: a cohort study. BMJ Open. 2(1):e000650.
   PubMed Web of Science ®Google Scholar
• Stoller RJ. 1975. Perversion: the erotic form of hatred. London: Karnac.
   Google Scholar
• Stone E, Thurston G. 1959. Castration for sexual offenders. Med Legal J. 27:136–139.
   PubMedGoogle Scholar
• Stone TH, Winslade WJ, Klugman CM. 2000. Sex offenders, sentencing laws and pharmaceutical treatment: a prescription for failure. Behav Sci Law. 18(1):83–110.
   PubMed Web of Science ®Google Scholar
• Sturup GK. 1972. Castration: the total treatment. Int Psychiatry Clin. 8:175–195.
   Google Scholar
• Symmers W. 1968. Carcinoma of the breast in transsexual individuals after surgical and hormonal interference with primary and secondary sex characteristics. Br Med J. 2(5597):83–85.
   PubMed Web of Science ®Google Scholar
• Taktak S, Yılmaz E, Karamustafalıoglu O, Ünsal A. 2016. Characteristics of paraphilics in Turkey: a retrospective study—20 years. Int J Law Psychiatry. 49:22–30.
   PubMed Web of Science ®Google Scholar
• Tardieu A. 1878. Etude médico-légale sur les attentats aux moeurs. 7th ed. Paris: Librairie JB Baillère et fils.
   Google Scholar
• Tenbergen G, Wittfoth M, Frieling H, Ponseti J, Walter M, Walter H, Beier KM, Schiffer B, Kruger THC. 2015. The neurobiology and psychology of pedophilia: recent advances and challenges. Front Hum Neurosci. 9(344):1–20.
   PubMed Web of Science ®Google Scholar
• Tennent G, Bancroft J, Cass J. 1974. The control of deviant sexual behavior by drugs: a double-blind controlled study of benperidol, chlorpromazine, and placebo. Arch Sex Behav. 3(3):261–271.
   PubMed Web of Science ®Google Scholar
• Tesson J, Cordier B, Thibaut F. 2012. Assessment of a new law for sex offenders implemented in France in 1998. Encéphale. 38(2):133–140.
   PubMed Web of Science ®Google Scholar
• Thibaut F. 2003. Perspectives on treatment interventions in paraphilias. In: Soares JC Gershon S, editors. The handbook of medical psychiatry. New York (NY): Marcel Dekker; p. 909–918.
   Google Scholar
• Thibaut F. 2013. Approche psychiatrique des déviances sexuelles. Paris: Springer; p. 130.
   Google Scholar
• Thibaut F. 2015. Les abus sexuels: des clefs indispensables pour comprendre, aider et prévenir. Paris: Odile Jacob; p. 235.
   Google Scholar
• Thibaut F. 2018. Incorporating pharmacological treatment strategies. In: Birchard T, Benfield J, editors. The Routledge international handbook of sexual addiction. Abingdon: Routledge International Handbooks series; Taylor and Francis; p. 282–292.
   Google Scholar
• Thibaut F, Bradford JM, Briken P, DeLaBarra F, Häßler F, Cosyns P; on behalf of the WFSBP Task Force on Sexual Disorders. 2016. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the treatment of adolescent sexual offenders with paraphilic disorders. World J Biol Psychiatry. 17(1):2–38.
   PubMed Web of Science ®Google Scholar
• Thibaut F, Colonna L. 1992. Cyproterone acetate in the treatment of aggression. Am J Psychiatry. 149(3):411.
   PubMed Web of Science ®Google Scholar
• Thibaut F, Cordier B, Kuhn J. 1996. Gonadotrophin hormone-releasing hormone agonist in cases of severe paraphilia: a lifetime treatment? Psychoneuroendocrinology. 21(4):411–419.
   PubMed Web of Science ®Google Scholar
• Thibaut F, Cordier B, Kuhn JM. 1993. Effect of a long-lasting gonodatrophin hormone-releasing hormone agonist in six cases of severe male paraphilia. Acta Psychiatr Scand. 87(6):445–450.
   PubMed Web of Science ®Google Scholar
• Thibaut F, Kuhn JM, Colonna L. 1991. A possible antiagressive effect of cyproterone acetate. Br J Psychiatry. 159(2):298–299.
   PubMed Web of Science ®Google Scholar
• Thibaut F, Kuhn JM, Cordier B. 1998. Hormone treatment of sex offenses. Encéphale. 24:132–137.
   PubMed Web of Science ®Google Scholar
• Thibaut F, DeLaBarra F, Gordon H, Cosyns P, Bradford JMW; the WFSBP Task Force on Sexual Disorders. 2010. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of paraphilias. World J Biol Psychiatry. 11(4):604–655.
   PubMed Web of Science ®Google Scholar
• Thuswaldner J, Fedoroff JP. 2020. Transdermal estradiol as a novel off-label treatment for Peyronie's disease: a case report. University of Ottawa J Medicine. 10(1). In press.
   Google Scholar
• Tozdan S, Briken P. 2015. The earlier, the worse? Age of onset of sexual interest in children. J Sex Med. 12(7):1602–1608.
   PubMed Web of Science ®Google Scholar
• Tozdan S, Briken P. 2017. Accepting sexual interest in children as unchangeable: one claim fits for all? Comments on Grundmann, Krupp, Scherner, Amelung, and Beier’s “stability of self-reported arousal to sexual fantasies involving children in a clinical sample of pedophiles and hebephiles. Arch Sex Behav. 46(2):331–333.
   PubMed Web of Science ®Google Scholar
• Tozdan S, Briken P. 2019. Age of onset and its correlates in men with sexual interest in children. Sex Med. 7(1):61–71.
   PubMed Web of Science ®Google Scholar
• Tozdan S, Kalt A, Dekker A, Keller LB, Thiel S, Müller JL, Briken P. 2018. Why information matters: examining the consequences of suggesting that pedophilia is immutable. Int J Offender Ther Comp Criminol. 62(5):1241–1261.
   PubMed Web of Science ®Google Scholar
• Tozdan S, Kalt A, Keller LB, Briken P. 2018. Keep faith in yourself! 2018a. A pilot study on the relevance of specific self-efficacy for modifying sexual interest in children among men with a risk to sexually abuse children. J Sex Marital Ther. 44(6):591–604.
   PubMed Web of Science ®Google Scholar
• Trottier D, Rouleau JL, Renaud P, Goyette M. 2014. Using eye tracking to identify faking attempts during penile plethysmography assessment. J Sex Res. 51(8):946–955.
   PubMed Web of Science ®Google Scholar
• Turner D, Basdekis-Jozsa R, Briken P. 2013. Prescription of testosterone-lowering medications for sex offender treatment in German forensic-psychiatric institutions. J Sex Med. 10(2):570–578.
   PubMed Web of Science ®Google Scholar
• Turner D, Basdekis-Jozsa R, Dekker A, Briken P. 2014. Which factors influence the appropriateness of testosterone-lowering medications for sex offenders? A survey among clinicians from German forensic-psychiatric institutions. World J Biol Psychiatry. 15(6):472–478.
   PubMed Web of Science ®Google Scholar
• Turner D, Briken P. 2018. Treatment of paraphilic disorders in sexual offenders or men with a risk of sexual offending with luteinizing hormone-releasing hormone agonists: an updated systematic review. J Sex Med. 15(1):77–93.
   PubMed Web of Science ®Google Scholar
• Vance MA, Smith JA. 1984. Endocrine and clinical effects of leuprolide in prostate cancer. Clin Pharmacol Ther. 36(3):350–354.
   PubMed Web of Science ®Google Scholar
• Varela D, Black DW. 2002. Pedophilia treated with carbamazepine and clonazepam. Am J Psychiatry. 159(7):1245–1246.
   PubMed Web of Science ®Google Scholar
• Voß T, Klemke K, Schneider-Njepel V, Kröber HL. 2016. When yes, for how long?-Duration of antiandrogenic treatment of sexual offenders with paraphilic disorders. Forens Psychiatr Psychol Kriminol. 10(1):21–31.
   Web of Science ®Google Scholar
• Wainberg ML, Muench F, Morgenstern J, Hollander E, Irwin TW, Parsons JT, Allen A, O'Leary A. 2006. A double-blind study of citalopram versus placebo in the treatment of compulsive sexual behaviors in gay and bisexual men. J Clin Psychiatry. 67(12):1968–1973.
   PubMed Web of Science ®Google Scholar
• Walter M, Witzel J, Wiebking C, Gubka U, Rotte M, Schiltz K, Bermpohl F, Tempelmann C, Bogerts B, Heinze HJ, et al. 2007. Pedophilia is linked to reduced activation in hypothalamus and lateral prefrontal cortex during visual erotic stimulation. Biol Psychiatry. 62(6):698–701.
   PubMed Web of Science ®Google Scholar
• Walton JS, Chou S. 2015. The effectiveness of psychological treatment for reducing recidivism in child molesters: a systematic review of randomized and nonrandomized studies. Trauma Viol Abuse. 16(4):401–417.
   PubMed Web of Science ®Google Scholar
• Wang SC, Kao YC, Liu YP. 2014. Divalproex sodium and quetiapine treatment of a pedophile with bipolar spectrum disorder. J Neuropsychiatry Clin Neurosci. 26(3):E47–E48.
   PubMed Web of Science ®Google Scholar
• Ward N. 1975. Successful lithium treatment of transvestism associated with manic-depression. J Nerv Ment Dis. 161:204–206.
   PubMed Web of Science ®Google Scholar
• Ward T, Gannon TA, Birgden A. 2007. Human rights and the treatment of sex offenders. Sex Abuse. 19(3):195–216.
   PubMed Web of Science ®Google Scholar
• Wawrose FE, Sisto TM. 1992. Clomipramine and a case of exhibitionism. Am J Psychiatry. 149(6):843.
   PubMed Web of Science ®Google Scholar
• Weinberger LE, Sreenivasan S, Garrick T, Osran H. 2005. The Impact of surgical castration on sexual recidivism risk among sexually violent predatory offenders. J Am Acad Psychiatry Law. 33:16–36.
   PubMed Web of Science ®Google Scholar
• Weiner MF, Denke M, Williams K, Guzman R. 1992. Intramuscular medroxyprogesterone acetate for sexual aggression in elderly men. Lancet. 339(8801):1121–1122.
   PubMed Web of Science ®Google Scholar
• White P, Bradley C, Ferriter M, Hatzipetrou L. 2000. Management for people with disorders of sexual preference and for convicted sexual offenders. Cochrane Database Syst Rev. (2):CD000251.
   PubMedGoogle Scholar
• Whittaker LH. 1959. Estrogens and psychosexual disorders. Med J Aust. 2:547–549.
   Google Scholar
• Wille R, Beier KM. 1989. Castration in Germany. Ann Sex Res. 2(2):103–133.
   Google Scholar
• Wilson RJ, Abracen J, Looman J, Picheca JE, Ferguson M. 2011. Pedophilia: an evaluation of diagnostic and risk prediction methods. Sex Abuse. 23(2):260–274.
   PubMed Web of Science ®Google Scholar
• Wincze JP, Bansal S, Malamud M. 1986. Effects of medroxyprogesterone acetate on subjective arousal, arousal to erotic stimulation, and nocturnal penile tumescence in male sex offenders. Arch Sex Behav. 15(4):293–305.
   PubMed Web of Science ®Google Scholar
• Winder B, Lievesley R, Elliot H, Hocken K, Faulkner J, Norman C, Kaul A. 2018. Evaluation of the use of pharmacological treatment with prisoners experiencing high levels of hypersexual disorder. J Forens Psychiatr Psychol. 29(1):53–71.
   Web of Science ®Google Scholar
• Witjas T, Eusebio A, Fluchère F, Azulay JP. 2012. Addictive behaviors and Parkinson’s disease. Rev Neurol. 168(8–9):624–633.
   PubMed Web of Science ®Google Scholar
• World Health Organization. 2019. ICD-11 for Mortality and Morbidity Statistics (Version : 04 / 2019). https://icd.who.int/browse11/l-m/en#/http%3a%2f%2fid.who.int%2ficd%2fentity%2f2110604642.
   Google Scholar
• Yafi FA, Sharlip ID, Becher EF. 2018. Update on the safety of phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction. Sex Med Rev. 6(2):242–252.
   PubMed Web of Science ®Google Scholar
• Yang FW, Liang CS. 2010. Paraphilias in schizophrenia: differential diagnosis and treatment with selective serotonin reuptake inhibitors. Prog Neuropsychopharmacol Biol Psychiatry. 34(6):1126–1127.
   PubMed Web of Science ®Google Scholar
• Zbytovský J. 1993. Haloperidol decanoate in the treatment of sexual deviations. Cesk Psychiatr. 89(1):15–17.
   PubMedGoogle Scholar
• Zohar J, Kaplan Z, Benjamin J. 1994. Compulsive exhibitionism successfully treated with fluvoxamine: a controlled case study. J Clin Psychiatry. 56(3):265–266.
   Google Scholar
• Zourkova A. 2000. Use of lithium and depot neuroleptics in the treatment of paraphilias. J Sex Marital Ther. 26(4):359–360.
   PubMed Web of Science ®Google Scholar
• Zourkova A. 2002. Psychotropic drugs in the treatment of paraphilic behaviour. Sci Med Fac Med Univ Brun Masarykianae. 75(6):277–282.
   Google Scholar
• Zverina J, Zimanova J, Bartova D. 1991. Catamnesis of a group of 44 castrated sexual offenders. Cesk Psychiatr. 87(1):28–34.
   PubMedGoogle Scholar